Joseph Shrager

4.9/5

Biography

Dr. Shrager assumed the role of Professor and Chief of the Division of Thoracic Surgery in July 2008. He came to Stanford from the University of Pennsylvania School of Medicine where he served as Associate Professor and Chief of Thoracic Surgery at the Hospital of the University of Pennsylvania and Pennsylvania Hospital. He earned his medical degree at Harvard, trained in surgery at Penn, and completed his thoracic surgery training at Massachusetts General Hospital.

Dr. Shrager has been identified as one of “America’s Top Doctors” and one of “America’s Top Doctors for Cancer” in Castle Connolly’s prestigious listings for multiple years running. Dr. Shrager has been awarded US News and World Report “Top Doctor” recognition in every year since that rating system was inaugurated in 2012 ; this award places him among the top 1% of thoracic surgeons nationwide based upon reviews by physician-peers. Evidence of his expert status among his peers also includes membership on the editorial board of the Annals of Thoracic Surgery.

Dr. Shrager practices all aspects of thoracic surgery but has specials interest and experience in lung cancer, surgery for emphysema, and mediastinal diseases. His clinical publications reflect these interests. In all cases, he looks towards minimally invasive approaches where appropriate, including VATS (thoracoscopic) lobectomy for early stage lung cancer and transcervical thymectomy.

In the basic research realm, Dr. Shrager has focused upon the responses of the respiratory muscles to various disease states and interventions. His lab’s work has been published in important journals such as The New England Journal of Medicine, The Journal of Thoracic and Cardiovascular Surgery, and The American Journal of Respiratory and Critical Care Medicine.

View Full Biography

Professional Summary

Education & Certifications

Board Certification: American Board of Thoracic Surgery, Thoracic and Cardiac Surgery (1999)
Board Certification: American Board of Surgery, General Surgery (2009)
Residency: Massachusetts General Hospital Thoracic Surgery (1997) MA
- Residency: Hospital of University of Pennsylvania Surgery Residency (1995) PA
- Medical Education: Harvard Medical School (1988) MA
- Thoracic Surgery, Massachusetts General Hospital, Thoracic Surgery (1997)
- Surgery Training, Hospital of the Univ of Penn, Surgery (1995)
- MD, Harvard University, Medicine (1988)

View More Education & Certifications

Honors & Awards

"Top Docs" Listing, Philadelphia Magazine (2002, 2005, 2006, 2007)
"Top Doctors" Listing, "America's Top Doctors for Cancer -- peer-elected (2006,07,08 09 10 11 12 13 14 15 16 17 etc)
"Top Doctors" Listing, "America's Top Doctors" - peer elected (2007,08,09,10,11,12, 13, 14, 15, 16, 17 etc)
- "Top Doctors" Listing, Castle-Connolly, San Francisco Magazine (2009-2024 yearly)
- 2nd Edward D. Churchill Research Scholarship, American Association for Thoracic Surgery (1999-2001)
- Cabot Graduation Prize, Harvard Medical School (1988)
- Elected Member, American Association for Thoracic Surgery (2002)
- Elected Member, American Surgical Association (2010)
- Elected Member, Society for Clinical Surgery (2008)
- Elected Member, Society of Clinical Surgery (2008)
- Fellow, American College of Chest Physicians (2000)
- Fellow, American College of Surgeons (2001)
- Havighurst Graduation Prize, Amherst College (Top History Thesis) (1984)
- Manstein Graduation Prize, Amherst College (Top Premed Athlete) (1984)
- National Research Service Award, National Institutes of Health (1990-1992)
- Phi Beta Kappa, Junior year induction, Amherst College (1983)
- Simpson Fellowship, (For study at Harvard Medical School) (1984-1988)
- Summa Cum Lauda, Amherst College (1984)
- William I Inouye Award for Excellence in Teaching, Department of Surgery, University of Pennsylvania Sch. of Med. (1991)

View More Honors & Awards

Memberships

Chair, Society of Thoracic Surgeons, Workforce on General Thoracic Surger (2023 - Present)
Member, NCCN, Policy Advisory Committee (2019 - Present)
Member, American Association for Thoracic Surgery (2004 - Present)
- Member, Society of Thoracic Surgeons (1998 - Present)
- Member, American Surgical Association (2008 - Present)
- Member, Society of Clinical Surgery (2007 - Present)

View More Memberships

Administrative Appointments

Chief, Section of General Thoracic Surgery, UPenn (2003 - 2007)
Chief, Stanford Division of Thoracic Surgery (2008 - Present)
Co-Director, Stanford Center for Minimally Invasive Thoracic Surgery (SMITS) (2012 - Present)
- Director, Stanford Respiratory Muscle Research Laboratory (2008 - Present)
- Editorial Board Member, Annals of Thoracic Surgery (2001 - 2018)
- Member, STS Workforce on Evidence-based Surgery (2006 - Present)
- Physician Leader Thoracic Oncology CCP, Stanford Cancer Center (2010 - Present)

View More Administrative Appointments

Publications

Thoracoscopic lung biopsy - Five commonly asked questions about video-assisted thoracic surgery
Shrager, J. B., & Kaiser, L. R. (1999). Thoracoscopic lung biopsy - Five commonly asked questions about video-assisted thoracic surgery. POSTGRADUATE MEDICINE, 106(4), 139-?
Lymphangioleiomyomatosis: The surgeon's role in diagnosis
Deeb, M., Shrager, J. B., Edelman, J. D., & Kaiser, L. (2000). Lymphangioleiomyomatosis: The surgeon's role in diagnosis. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 119(3), 622–623.
Lung volume reduction surgery.
Shrager, J. B., Kaiser, L. R., & Edelman, J. D. (2000). Lung volume reduction surgery. Current Problems in Surgery, 37(4), 253–317.
- Lobectomy with tangential pulmonary artery resection without regard to pulmonary function
  Shrager, J. B., Lambright, E. S., McGrath, C. M., Wahl, P. M., Deeb, M. E., Friedberg, J. S., & Kaiser, L. R. (2000). Lobectomy with tangential pulmonary artery resection without regard to pulmonary function. ANNALS OF THORACIC SURGERY, 70(1), 234–239.
- Human skeletal myosin heavy chain genes are tightly linked in the order embryonic-IIa-IId/x-IIb-perinatal-extraocular
  Shrager, J. B., Desjardins, P. R., Burkman, J. M., Konig, S. K., Stewart, D. R., Su, L., … Stedman, H. H. (2000). Human skeletal myosin heavy chain genes are tightly linked in the order embryonic-IIa-IId/x-IIb-perinatal-extraocular. JOURNAL OF MUSCLE RESEARCH AND CELL MOTILITY, 21(4), 345–355.
- Lung volume reduction surgery restores the normal diaphragmatic length-tension relationship in emphysematous rats
  Shrager, J. B., Kim, D. K., Hashmi, Y. J., Lankford, E. B., Wahl, P., Stedman, H. H., … Kaiser, L. R. (2001). Lung volume reduction surgery restores the normal diaphragmatic length-tension relationship in emphysematous rats. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 121(2), 217–24.
- Bronchial anastomotic stricture caused by ossification of an intercostal muscle flap
  Deeb, M. E., Sterman, D. H., Shrager, J. B., & Kaiser, L. R. (2001). Bronchial anastomotic stricture caused by ossification of an intercostal muscle flap. ANNALS OF THORACIC SURGERY, 71(5), 1700–1702.
- Successful-experience with simultaneous lung volume reduction and cardiac procedures
  Shrager, J. B., Kozyak, B. W., Roberts, J. R., Bavaria, J. E., Friedberg, J. S., Kaiser, L. R., & Rosengard, B. R. (2001). Successful-experience with simultaneous lung volume reduction and cardiac procedures. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 122(1), 196–197.
- Expanded indications for transcervical thymectomy in the management of anterior mediastinal masses
  Deeb, M. E., Brinster, C. J., Kucharzuk, J., Shrager, J. B., & Kaiser, L. R. (2001). Expanded indications for transcervical thymectomy in the management of anterior mediastinal masses. ANNALS OF THORACIC SURGERY, 72(1), 208–211.
- Risk of death from intercurrent disease is not excessively increased by modern postoperative radiotherapy for high-risk resected non-small-cell lung carcinoma
  Machtay, M., Lee, J. H., Shrager, J. B., Kaiser, L. R., & Glatstein, E. (2001). Risk of death from intercurrent disease is not excessively increased by modern postoperative radiotherapy for high-risk resected non-small-cell lung carcinoma. JOURNAL OF CLINICAL ONCOLOGY, 19(19), 3912–3917.
- Sarcomeres are added in series to emphysematous rat diaphragm after lung volume reduction surgery
  Shrager, J. B., Kim, D. K., Hashmi, Y. J., Stedman, H. H., Zhu, J. L., Kaiser, L. R., & LEVINE, S. (2002). Sarcomeres are added in series to emphysematous rat diaphragm after lung volume reduction surgery. CHEST, 121(1), 210–215.
- Current presentation and optimal surgical management of sternoclavicular joint infections
  Song, H. K., Guy, T. S., Kaiser, L. R., & Shrager, J. B. (2002). Current presentation and optimal surgical management of sternoclavicular joint infections. ANNALS OF THORACIC SURGERY, 73(2), 427–431.
- Suction vs water seal after pulmonary resection - A randomized prospective study
  Marshall, M. B., Deeb, M. E., Bleier, J. I. S., Kucharczuk, J. C., Friedberg, J. S., Kaiser, L. R., & Shrager, J. B. (2002). Suction vs water seal after pulmonary resection - A randomized prospective study. CHEST, 121(3), 831–35.
- Evolutionary implications of three novel members of the human sarcomeric myosin heavy chain gene family
  Desjardins, P. R., Burkman, J. M., Shrager, J. B., Allmond, L. A., & Stedman, H. H. (2002). Evolutionary implications of three novel members of the human sarcomeric myosin heavy chain gene family. MOLECULAR BIOLOGY AND EVOLUTION, 19(4), 375–393.
- Osteogenic sarcoma presenting with lung metastasis
  Staddon, A. P., Lackman, R., Robinson, K., Shrager, J. B., & Warhol, M. (2002). Osteogenic sarcoma presenting with lung metastasis. ONCOLOGIST, 7(2), 144–153.
- Pathological response to preoperative chemoradiation worsens with anemia in non-small cell lung cancer patients
  Robnett, T. J., Machtay, M., Hahn, S. M., Shrager, J. B., Freidberg, J. S., & Kaiser, L. R. (2002). Pathological response to preoperative chemoradiation worsens with anemia in non-small cell lung cancer patients. CANCER JOURNAL, 8(3), 263–267.
- Transcervical thymectomy for myasthenia gravis achieves results comparable to thymectomy by sternotomy
  Shrager, J. B., Deeb, M. E., Mick, R., Brinster, C. J., Childers, H. E., Marshall, M. B., … Kaiser, L. R. (2002). Transcervical thymectomy for myasthenia gravis achieves results comparable to thymectomy by sternotomy. ANNALS OF THORACIC SURGERY, 74(2), 320–326.
- Benign expectoration of a surgical clip through a pneumonectomy stump
  Ahmed, Z., Kaiser, L. R., & Shrager, J. B. (2002). Benign expectoration of a surgical clip through a pneumonectomy stump. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 124(5), 1025–1026.
- Evaluating respiratory muscle adaptations - A new approach
  LEVINE, S., Nguyen, T., Kaiser, L. R., & Shrager, J. B. (2002). Evaluating respiratory muscle adaptations - A new approach. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 166(11), 1418–1419.
- Inspiratory loading does not accelerate dystrophy in mdx mouse diaphragm: implications for regenerative therapy
  Krupnick, A. S., Zhu, J. L., Nguyen, T., Kreisel, D., Balsara, K. R., Lankford, E. B., … Shrager, J. B. (2003). Inspiratory loading does not accelerate dystrophy in mdx mouse diaphragm: implications for regenerative therapy. JOURNAL OF APPLIED PHYSIOLOGY, 94(2), 411–419.
- Mediastinal talcoma masquerading as thymoma
  Ahmed, Z., & Shrager, J. B. (2003). Mediastinal talcoma masquerading as thymoma. ANNALS OF THORACIC SURGERY, 75(2), 568–569.
- Myosin heavy chain and physiological adaptation of the rat diaphragm in elastase-induced emphysema
  Kim, D. K., Zhu, J. L., Kozyak, B. W., Burkman, J. M., Rubinstein, N. A., Lankford, E. B., … Shrager, J. B. (2003). Myosin heavy chain and physiological adaptation of the rat diaphragm in elastase-induced emphysema. RESPIRATORY RESEARCH, 4(1).
- Omentum is highly effective in the management of complex cardiothoracic surgical problems
  Shrager, J. B., Wain, J. C., Wright, C. D., Donahue, D. M., Vlahakes, G. J., Moncure, A. C., … Mathisen, D. J. (2003). Omentum is highly effective in the management of complex cardiothoracic surgical problems. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 125(3), 526–32.
- Tracheal trauma.
  Shrager, J. B. (2003). Tracheal trauma. Chest Surgery Clinics of North America, 13(2), 291–304.
- Human diaphragm remodeling associated with chronic obstructive pulmonary disease - Clinical implications
  Levine, S., Nguyen, T., Kaiser, L. R., Rubinstein, N. A., Maislin, G., Gregory, C., … Shrager, J. B. (2003). Human diaphragm remodeling associated with chronic obstructive pulmonary disease - Clinical implications. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 168(6), 706–13.
- A PCR-BASED ASSAY FOR THE WILD-TYPE DYSTROPHIN GENE TRANSFERRED INTO THE MDX MOUSE
  Shrager, J. B., Naji, A., Kelly, A. M., & Stedman, H. H. (1992). A PCR-BASED ASSAY FOR THE WILD-TYPE DYSTROPHIN GENE TRANSFERRED INTO THE MDX MOUSE. MUSCLE & NERVE, 15(10), 1133–1137.
- Comparison of stages I-II thymoma treated by complete resection with or without adjuvant radiation
  Singhal, S., Shrager, J. B., Rosenthal, D. I., LiVolsi, V. A., & Kaiser, L. R. (2003). Comparison of stages I-II thymoma treated by complete resection with or without adjuvant radiation. ANNALS OF THORACIC SURGERY, 76(5), 1635–1641.
- Two commonly used neoadjuvant chemoradiotherapy regimens for locally advanced stage III non-small cell lung carcinoma: Long-term results and associations with pathologic response
  Machtay, M., Lee, J. H., Stevenson, J. P., Shrager, J. B., Algazy, K. M., Treat, J., & Kaiser, L. R. (2004). Two commonly used neoadjuvant chemoradiotherapy regimens for locally advanced stage III non-small cell lung carcinoma: Long-term results and associations with pathologic response. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 127(1), 108–113.
- Myosin gene mutation correlates with anatomical changes in the human lineage
  Stedman, H. H., Kozyak, B. W., Nelson, A., Thesier, D. M., Su, L. T., Low, D. W., … Mitchell, M. A. (2004). Myosin gene mutation correlates with anatomical changes in the human lineage. NATURE, 428(6981), 415–18.
- Lung cancer in transplant recipients - A single-institution experience
  Ahmed, Z., Marshall, M. B., Kucharczuk, J. C., Kaiser, L. R., & Shrager, J. B. (2004). Lung cancer in transplant recipients - A single-institution experience. ARCHIVES OF SURGERY, 139(8), 902–906.
- Hyperpolarized helium-3 MR imaging of pulmonary function
  Ishii, M., Fischer, M. C., Emami, K., Alavi, A., Spector, Z. Z., Yu, J. S., … Rizi, R. R. (2005). Hyperpolarized helium-3 MR imaging of pulmonary function. RADIOLOGIC CLINICS OF NORTH AMERICA, 43(1), 235-?
- Effect of chronic obstructive pulmonary disease on calcium pump ATPase expression in human diaphragm
  Nguyen, T., Rubinstein, N. A., Vijayasarathy, C., Rome, L. C., Kaiser, L. R., Shrager, J. B., & Levine, S. (2005). Effect of chronic obstructive pulmonary disease on calcium pump ATPase expression in human diaphragm. JOURNAL OF APPLIED PHYSIOLOGY, 98(6), 2004–2010.
- Catamenial pneumothorax: optimal hormonal and surgical management
  Marshall, M. B., Ahmed, Z., Kucharczuk, J. C., Kaiser, L. R., & Shrager, J. B. (2005). Catamenial pneumothorax: optimal hormonal and surgical management. EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 27(4), 662–666.
- Which patients with stage III non-small cell lung cancer should undergo surgical resection?
  Patel, V., & Shrager, J. B. (2005). Which patients with stage III non-small cell lung cancer should undergo surgical resection? ONCOLOGIST, 10(5), 335–344.
- Pain and physical function are similar following axillary, muscle-sparing vs posterolateral thoracotomy
  Ochroch, E. A., Gottschalk, A., Augoustides, J. G., Aukburg, S. J., Kaiser, L. R., & Shrager, J. B. (2005). Pain and physical function are similar following axillary, muscle-sparing vs posterolateral thoracotomy. CHEST, 128(4), 2664–2670.
- Comparative study of subxiphoid versus video-thoracoscopic pericardial "'window"
  O'Brien, P. K. H., Kucharczuk, J. C., Marshall, M. B., Friedberg, J. S., Chen, Z., Kaiser, L. R., & Shrager, J. B. (2005). Comparative study of subxiphoid versus video-thoracoscopic pericardial "'window". ANNALS OF THORACIC SURGERY, 80(6), 2013–2019.
- Invited commentary.
  Shrager, J. B. (2006). Invited commentary. Annals of Thoracic Surgery, 81(1), 334-?
- Anterior surgical approaches to the thoracic outlet
  Marshall, M. B., Kucharczuk, J. C., Shrager, J. B., & Kaiser, L. R. (2006). Anterior surgical approaches to the thoracic outlet. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 131(6), 1255–1260.
- Parasternal intercostal muscle remodeling in severe chronic obstructive pulmonary disease
  Levine, S., Nguyen, T., Friscia, M., Zhu, J., Szeto, W., Kucharczuk, J. C., … Shrager, J. B. (2006). Parasternal intercostal muscle remodeling in severe chronic obstructive pulmonary disease. JOURNAL OF APPLIED PHYSIOLOGY, 101(5), 1297–1302.
- Outcomes after 151 extended transcervical thymectomies for myasthenia gravis
  Shrager, J. B., Nathan, D., Brinster, C. J., Yousuf, O., Spence, A., Chen, Z., & Kaiser, L. R. (2006). Outcomes after 151 extended transcervical thymectomies for myasthenia gravis. ANNALS OF THORACIC SURGERY, 82(5), 1863–1869.
- Cytokine response is lower after lung volume reduction through bilateral thoracoscopy versus sternotomy
  Friscia, M. E., Zhu, J., Kolff, J. W., Chen, Z., Kaiser, L. R., Deutschman, C. S., & Shrager, J. B. (2007). Cytokine response is lower after lung volume reduction through bilateral thoracoscopy versus sternotomy. ANNALS OF THORACIC SURGERY, 83(1), 252–56.
- Complications of video-assisted thoracoscopic lung biopsy in patients with interstitial lung disease
  Kreider, M. E., Hansen-Flaschen, J., Ahmad, N. N., Rossman, M. D., Kaiser, L. R., Kucharczuk, J. C., & Shrager, J. B. (2007). Complications of video-assisted thoracoscopic lung biopsy in patients with interstitial lung disease. ANNALS OF THORACIC SURGERY, 83(3), 1140–1145.
- Early changes of lung function and structure in an elastase model of emphysema - a hyperpolarized He-3 MRI study
  Emami, K., Cadman, R. V., Woodburn, J. M., Fischer, M. C., Kadlecek, S. J., Zhu, J., … Rizi, R. R. (2008). Early changes of lung function and structure in an elastase model of emphysema - a hyperpolarized He-3 MRI study. JOURNAL OF APPLIED PHYSIOLOGY, 104(3), 773–786.
- Rapid disuse atrophy of diaphragm fibers in mechanically ventilated humans
  Levine, S., Nguyen, T., Taylor, N., Friscia, M. E., Budak, M. T., Rothenberg, P., … Shrager, J. B. (2008). Rapid disuse atrophy of diaphragm fibers in mechanically ventilated humans. NEW ENGLAND JOURNAL OF MEDICINE, 358(13), 1327–35.
- Thoracoscopic total parietal pleurectomy for primary spontaneous pneumothorax
  Nathan, D. P., Taylor, N. E., Low, D. W., Raymond, D., & Shrager, J. B. (2008). Thoracoscopic total parietal pleurectomy for primary spontaneous pneumothorax. ANNALS OF THORACIC SURGERY, 85(5), 1825–27.
- Extended transcervical thymectomy in the treatment of myasthenia gravis
  Khicha, S. G., Kaiser, L. R., & Shrager, J. B. (2008). Extended transcervical thymectomy in the treatment of myasthenia gravis. Presented at the 11th International Conference on Myasthenia Gravis and Related Disorder, CHICAGO,IL,IL,IL,IL: WILEY-BLACKWELL.
- THE MDX MOUSE DIAPHRAGM REPRODUCES THE DEGENERATIVE CHANGES OF DUCHENNE MUSCULAR-DYSTROPHY
  Stedman, H. H., Sweeney, H. L., Shrager, J. B., Maguire, H. C., Panettieri, R. A., Petrof, B., … Kelly, A. M. (1991). THE MDX MOUSE DIAPHRAGM REPRODUCES THE DEGENERATIVE CHANGES OF DUCHENNE MUSCULAR-DYSTROPHY. NATURE, 352(6335), 536–39.
- 3 WOMEN AT JOHNS-HOPKINS - PRIVATE PERSPECTIVES ON MEDICAL COEDUCATION IN THE 1890S
  Shrager, J. B. (1991). 3 WOMEN AT JOHNS-HOPKINS - PRIVATE PERSPECTIVES ON MEDICAL COEDUCATION IN THE 1890S. ANNALS OF INTERNAL MEDICINE, 115(7), 564–569.
- Thymoma
  Shrager, J. B. (2009). Thymoma. ANNALS OF THORACIC SURGERY, 87(1), 339–41.
- Intraoperative and postoperative management of air leaks in patients with emphysema.
  Shrager, J. B., DeCamp, M. M., & Murthy, S. C. (2009). Intraoperative and postoperative management of air leaks in patients with emphysema. Thoracic Surgery Clinics, 19(2), 223-?
- Mediastinoscopy: Still the Gold Standard
  Shrager, J. B. (2010). Mediastinoscopy: Still the Gold Standard. ANNALS OF THORACIC SURGERY, 89(6), S2084–S2089.
- Extended Transcervical Thymectomy: The Ultimate Minimally Invasive Approach
  Shrager, J. B. (2010). Extended Transcervical Thymectomy: The Ultimate Minimally Invasive Approach. ANNALS OF THORACIC SURGERY, 89(6), S2128–S2134.
- Evidence-based suggestions for management of air leaks.
  Merritt, R. E., Singhal, S., & Shrager, J. B. (2010). Evidence-based suggestions for management of air leaks. Thoracic Surgery Clinics, 20(3), 435–48.
- Invited commentary.
  Shrager, J. B. (2010). Invited commentary. Annals of Thoracic Surgery, 90(6), 1785-?
- Endobronchial Valves for Emphysema
  Chang, E.-T. (2011). Endobronchial Valves for Emphysema. NEW ENGLAND JOURNAL OF MEDICINE, 364(4), 382–82.
- Intrinsic apoptosis in mechanically ventilated human diaphragm: linkage to a novel Fos/FoxO1/Stat3-Bim axis
  Tang, H., Lee, M., Budak, M. T., Pietras, N., Hittinger, S., Vu, M., … Shrager, J. B. (2011). Intrinsic apoptosis in mechanically ventilated human diaphragm: linkage to a novel Fos/FoxO1/Stat3-Bim axis. FASEB JOURNAL, 25(9), 2921–36.
- Improved Survival after Pulmonary Metastasectomy for Soft Tissue Sarcoma
  Predina, J. D., Puc, M. M., Bergey, M. R., Sonnad, S. S., Kucharczuk, J. C., Staddon, A., … Shrager, J. B. (2011). Improved Survival after Pulmonary Metastasectomy for Soft Tissue Sarcoma. JOURNAL OF THORACIC ONCOLOGY, 6(5), 913–19.
- Tumor Volume as a Potential Imaging-Based Risk-Stratification Factor in Trimodality Therapy for Locally Advanced Non-small Cell Lung Cancer
  Kozak, M. M., Murphy, J. D., Schipper, M. L., Donington, J. S., Zhou, L., Whyte, R. I., … Loo, B. W. (2011). Tumor Volume as a Potential Imaging-Based Risk-Stratification Factor in Trimodality Therapy for Locally Advanced Non-small Cell Lung Cancer. JOURNAL OF THORACIC ONCOLOGY, 6(5), 920–26.
- Benign emptying of the postpneumonectomy space.
  Merritt, R. E., Reznik, S. I., DaSilva, M. C., Sugarbaker, D. J., Whyte, R. I., Donahue, D. M., … Shrager, J. B. (2011). Benign emptying of the postpneumonectomy space. Annals of Thoracic Surgery, 92(3), 1076–81.
- Morbidity and Mortality After Esophagectomy Following Neoadjuvant Chemoradiation
  Merritt, R. E., Whyte, R. I., D'Arcy, N. T., Hoang, C. D., & Shrager, J. B. (2011). Morbidity and Mortality After Esophagectomy Following Neoadjuvant Chemoradiation. ANNALS OF THORACIC SURGERY, 92(6), 2034–40.
- Prophylaxis and Management of Atrial Fibrillation After General Thoracic Surgery
  Merritt, R. E., & Shrager, J. B. (2012). Prophylaxis and Management of Atrial Fibrillation After General Thoracic Surgery. THORACIC SURGERY CLINICS, 22(1), 13-?
- Invited commentary.
  Shrager, J. B. (2011). Invited commentary. Annals of Thoracic Surgery, 92(6), 2005–6.
- Prognostic PET F-18-FDG Uptake Imaging Features Are Associated with Major Oncogenomic Alterations in Patients with Resected Non-Small Cell Lung Cancer
  Nair, V. S., Gevaert, O., Davidzon, G., Napel, S., Graves, E. E., Hoang, C. D., … Plevritis, S. K. (2012). Prognostic PET F-18-FDG Uptake Imaging Features Are Associated with Major Oncogenomic Alterations in Patients with Resected Non-Small Cell Lung Cancer. CANCER RESEARCH, 72(15), 3725–34.
- Invited commentary.
  Shrager, J. B. (2012). Invited commentary. Annals of Thoracic Surgery, 94(1), 240-?
- Indications for Surgery in Patients with Localized Pulmonary Infection
  Merritt, R. E., & Shrager, J. B. (2012). Indications for Surgery in Patients with Localized Pulmonary Infection. THORACIC SURGERY CLINICS, 22(3), 325-?
- Cross-Species Functional Analysis of Cancer-Associated Fibroblasts Identifies a Critical Role for CLCF1 and IL-6 in Non-Small Cell Lung Cancer In Vivo
  Vicent, S., Sayles, L. C., Vaka, D., Khatri, P., Gevaert, O., Chen, R., … Sweet-Cordero, E. A. (2012). Cross-Species Functional Analysis of Cancer-Associated Fibroblasts Identifies a Critical Role for CLCF1 and IL-6 in Non-Small Cell Lung Cancer In Vivo. CANCER RESEARCH, 72(22), 5744–56.
- Approach to the patient with multiple lung nodules.
  Shrager, J. B. (2013). Approach to the patient with multiple lung nodules. Thoracic Surgery Clinics, 23(2), 257–66.
- VIDEO-ASSISTED THORACIC-SURGERY - THE CURRENT STATE-OF-THE-ART
  Kaiser, L. R., & Shrager, J. B. (1995). VIDEO-ASSISTED THORACIC-SURGERY - THE CURRENT STATE-OF-THE-ART. AMERICAN JOURNAL OF ROENTGENOLOGY, 165(5), 1111–1117.
- VILLOUS ADENOMA OF THE MAIN PANCREATIC DUCT - A CLUE TO THE PATHOGENESIS OF PANCREATIC MALIGNANCY
  Shrager, J. B., GREELISH, J., VANARSDALE, C., Furth, E., & Daly, J. M. (1994). VILLOUS ADENOMA OF THE MAIN PANCREATIC DUCT - A CLUE TO THE PATHOGENESIS OF PANCREATIC MALIGNANCY. SURGICAL ONCOLOGY-OXFORD, 3(4), 203–210.
- THE VINEBERG PROCEDURE - THE IMMEDIATE FORERUNNER OF CORONARY-ARTERY BYPASS-GRAFTING
  Shrager, J. B. (1994). THE VINEBERG PROCEDURE - THE IMMEDIATE FORERUNNER OF CORONARY-ARTERY BYPASS-GRAFTING. ANNALS OF THORACIC SURGERY, 57(5), 1354–1364.
- ADAPTATIONS IN MYOSIN HEAVY-CHAIN EXPRESSION AND CONTRACTILE FUNCTION IN DYSTROPHIC MOUSE DIAPHRAGM
  Petrof, B. J., Stedman, H. H., Shrager, J. B., Eby, J., Sweeney, H. L., & Kelly, A. M. (1993). ADAPTATIONS IN MYOSIN HEAVY-CHAIN EXPRESSION AND CONTRACTILE FUNCTION IN DYSTROPHIC MOUSE DIAPHRAGM. AMERICAN JOURNAL OF PHYSIOLOGY, 265(3), C834–C841.
- DYSTROPHIN PROTECTS THE SARCOLEMMA FROM STRESSES DEVELOPED DURING MUSCLE-CONTRACTION
  Petrof, B. J., Shrager, J. B., Stedman, H. H., Kelly, A. M., & Sweeney, H. L. (1993). DYSTROPHIN PROTECTS THE SARCOLEMMA FROM STRESSES DEVELOPED DURING MUSCLE-CONTRACTION. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 90(8), 3710–14.
- Treatment of refractory, nonmalignant hydrothorax with a pleurovenous shunt
  Park, S. Z., Shrager, J. B., Allen, M. S., & Nagorney, D. M. (1997). Treatment of refractory, nonmalignant hydrothorax with a pleurovenous shunt. ANNALS OF THORACIC SURGERY, 63(6), 1777–1779.
- Bronchopulmonary carcinoid tumors associated with Cushing's syndrome: A more aggressive variant of typical carcinoid
  Shrager, J. B., Wright, C. D., Wain, J. C., Torchiana, D. F., Grillo, H. C., & Mathisen, D. J. (1997). Bronchopulmonary carcinoid tumors associated with Cushing's syndrome: A more aggressive variant of typical carcinoid. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 114(3), 367–375.
- Determinants of time to opioid cessation post-surgery
  Ruchelli, G., Clay, D., Schmidt, P., Humphreys, K., Trafton, J., Dirbas, F., … Carroll, I. (2013). Determinants of time to opioid cessation post-surgery. JOURNAL OF PAIN, 14(4), S18–S18.
- The Society of Thoracic Surgeons Practice Guideline Series: Guidelines for the Management of Barrett's Esophagus With High-Grade Dysplasia
  Fernando, H. C., Murthy, S. C., Hofstetter, W., Shrager, J. B., Bridges, C., Mitchell, J. D., … Watson, T. J. (2009). The Society of Thoracic Surgeons Practice Guideline Series: Guidelines for the Management of Barrett's Esophagus With High-Grade Dysplasia. ANNALS OF THORACIC SURGERY, 87(6), 1993–2002.
- Management of Alveolar Air Leaks After Pulmonary Resection
  Singhal, S., Ferraris, V. A., Bridges, C. R., Clough, E. R., Mitchell, J. D., Fernando, H. C., & Shrager, J. B. (2010). Management of Alveolar Air Leaks After Pulmonary Resection. ANNALS OF THORACIC SURGERY, 89(4), 1327–35.
- Early outcomes after bilateral thoracoscopy versus median sternotomy for lung volume reduction.
  Puc, M. M., Sonnad, S. S., & Shrager, J. B. (2010). Early outcomes after bilateral thoracoscopy versus median sternotomy for lung volume reduction. Innovations (Philadelphia, Pa.), 5(2), 97–102.
- METABOLOMIC PROFILING OF LUNG ADENOCARCINOMA
  Hoang, C. D., Wu, M., Xu, Y., Peltz, G., Merritt, R., Whyte, R., & Shrager, J. (2010). METABOLOMIC PROFILING OF LUNG ADENOCARCINOMA. JOURNAL OF THORACIC ONCOLOGY, 5(5), S51–S52.
- MULTIPLE MICRORNA ARE DYSREGULATED IN MESOTHELIOMA
  Hoang, C. D., Xu, Y., Zheng, M., Peltz, G., Shrager, J., & Kratzke, R. (2010). MULTIPLE MICRORNA ARE DYSREGULATED IN MESOTHELIOMA. JOURNAL OF THORACIC ONCOLOGY, 5(5), S105–S106.
- Oxidative stress-responsive microRNA-320 regulates glycolysis in diverse biological systems
  Tang, H., Lee, M., Sharpe, O., Salamone, L., Noonan, E. J., Hoang, C. D., … Shrager, J. B. (2012). Oxidative stress-responsive microRNA-320 regulates glycolysis in diverse biological systems. FASEB JOURNAL, 26(11), 4710–21.
- A Dominant Adenocarcinoma With Multifocal Ground Glass Lesions Does Not Behave as Advanced Disease
  Gu, B., Burt, B. M., Merritt, R. E., Stephanie, S., Nair, V., Hoang, C. D., & Shrager, J. B. (2013). A Dominant Adenocarcinoma With Multifocal Ground Glass Lesions Does Not Behave as Advanced Disease. ANNALS OF THORACIC SURGERY. LOS ANGELES,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA: ELSEVIER SCIENCE INC.
- Diaphragm muscle atrophy in the mouse after long-term mechanical ventilation
  Tang, H., Lee, M., Khuong, A., Wright, E., & Shrager, J. B. (2013). Diaphragm muscle atrophy in the mouse after long-term mechanical ventilation. MUSCLE & NERVE, 48(2), 272–78.
- miR-1 Induces Growth Arrest and Apoptosis in Malignant Mesothelioma
  Xu, Y., Zheng, M., Merritt, R. E., Shrager, J. B., Wakelee, H. A., Kratzke, R. A., & Hoang, C. D. (2013). miR-1 Induces Growth Arrest and Apoptosis in Malignant Mesothelioma. CHEST, 144(5), 1632–43.
- A Rare Population of CD24(+)ITGB4(+)Notch(hi) Cells Drives Tumor Propagation in NSCLC and Requires Notch3 for Self-Renewal
  Zheng, Y., de la Cruz, C. C., Sayles, L. C., Alleyne-Chin, C., Vaka, D., Knaak, T. D., … Sweet-Cordero, E. A. (2013). A Rare Population of CD24(+)ITGB4(+)Notch(hi) Cells Drives Tumor Propagation in NSCLC and Requires Notch3 for Self-Renewal. CANCER CELL, 24(1), 59–74.
- An observational study of circulating tumor cells and (18)F-FDG PET uptake in patients with treatment-naive non-small cell lung cancer.
  Nair, V. S., Keu, K. V., Luttgen, M. S., Kolatkar, A., Vasanawala, M., Kuschner, W., … Kuhn, P. (2013). An observational study of circulating tumor cells and (18)F-FDG PET uptake in patients with treatment-naive non-small cell lung cancer. PloS One, 8(7).
- Adjuvant Cisplatin and Docetaxel for Non-small Cell Lung Cancer The Hospital of the University of Pennsylvania Experience
  Weiss, J., Eaby, B., Stevenson, J., Kucharczuk, J., Cooper, J., Kaiser, L., … Evans, T. (2010). Adjuvant Cisplatin and Docetaxel for Non-small Cell Lung Cancer The Hospital of the University of Pennsylvania Experience. JOURNAL OF THORACIC ONCOLOGY, 5(5), 667–72.
- Liquid chromatography/mass spectrometry methods for measuring dipeptide abundance in non-small-cell lung cancer.
  Wu, M., Xu, Y., Fitch, W. L., Zheng, M., Merritt, R. E., Shrager, J. B., … Hoang, C. D. (2013). Liquid chromatography/mass spectrometry methods for measuring dipeptide abundance in non-small-cell lung cancer. Rapid Communications in Mass Spectrometry : RCM, 27(18), 2091–98.
- Quantitative assessment of emphysema using hyperpolarized He-3 magnetic resonance imaging
  Spector, Z. Z., Emami, K., Fischer, M. C., Zhu, J., Ishii, M., Vahdat, V., … Rizi, R. R. (2005). Quantitative assessment of emphysema using hyperpolarized He-3 magnetic resonance imaging. MAGNETIC RESONANCE IN MEDICINE, 53(6), 1341–1346.
- A small animal model of regional alveolar ventilation using (HPHe)-He-3 MRI
  Spector, Z. Z., Emami, K., Fischer, M. C., Zhu, J., Ishii, M., Yu, J., … Rizi, R. R. (2004). A small animal model of regional alveolar ventilation using (HPHe)-He-3 MRI. ACADEMIC RADIOLOGY, 11(10), 1171–1179.
- Lymph Node Evaluation Achieved by Open Lobectomy Compared With Thoracoscopic Lobectomy for N0 Lung Cancer
  Merritt, R. E., Hoang, C. D., & Shrager, J. B. (2013). Lymph Node Evaluation Achieved by Open Lobectomy Compared With Thoracoscopic Lobectomy for N0 Lung Cancer. ANNALS OF THORACIC SURGERY, 96(4), 1171–77.
- mTORC1 promotes denervation-induced muscle atrophy through a mechanism involving the activation of FoxO and E3 ubiquitin ligases.
  Tang, H., Inoki, K., Lee, M., Wright, E., Khuong, A., Khuong, A., … Shrager, J. B. (2014). mTORC1 promotes denervation-induced muscle atrophy through a mechanism involving the activation of FoxO and E3 ubiquitin ligases. Science Signaling, 7(314), ra18-?
- An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage.
  Newman, A. M., Bratman, S. V., To, J., Wynne, J. F., Eclov, N. C. W., Modlin, L. A., … Diehn, M. (2014). An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage. Nature Medicine, 20(5), 548–54.
- An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage
  Newman, A. M., Bratman, S. V., To, J., Wynne, J. F., Eclov, N. C. W., Modlin, L. A., … Diehn, M. (2014). An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage. NATURE MEDICINE, 20(5), 552–58.
- A Meta-analysis of Lung Cancer Gene Expression Identifies PTK7 as a Survival Gene in Lung Adenocarcinoma.
  Chen, R., Khatri, P., Mazur, P. K., Polin, M., Zheng, Y., Vaka, D., … Sweet-Cordero, E. A. (2014). A Meta-analysis of Lung Cancer Gene Expression Identifies PTK7 as a Survival Gene in Lung Adenocarcinoma. Cancer Research, 74(10), 2892–2902.
- Prevention and management of postoperative air leaks.
  Burt, B. M., & Shrager, J. B. (2014). Prevention and management of postoperative air leaks. Annals of Cardiothoracic Surgery, 3(2), 216–18.
- Invited commentary.
  Shrager, J. B. (2014). Invited commentary. Annals of Thoracic Surgery, 97(1), 266–67.
- Invited commentary.
  Shrager, J. B. (2014). Invited commentary. Annals of Thoracic Surgery, 97(1), 229-?
- Increased Proteolysis, Myosin Depletion, and Atrophic AKT-FOXO Signaling in Human Diaphragm Disuse
  Levine, S., Biswas, C., Dierov, J., Barsotti, R., Shrager, J. B., Taitan Nguyen, N., … Budak, M. T. (2011). Increased Proteolysis, Myosin Depletion, and Atrophic AKT-FOXO Signaling in Human Diaphragm Disuse. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 183(4), 483–90.
- Should asymptomatic enlarged thymus glands be resected?
  Singla, S., Litzky, L. A., Kaiser, L. R., & Shrager, J. B. (2010). Should asymptomatic enlarged thymus glands be resected? JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 140(5), 977–83.
- Accuracy of Fluorodeoxyglucose-Positron Emission Tomography Within the Clinical Practice of the American College of Surgeons Oncology Group Z4031 Trial to Diagnose Clinical Stage I Non-Small Cell Lung Cancer
  Grogan, E. L., Deppen, S. A., Ballman, K. V., Andrade, G. M., Verdial, F. C., Aldrich, M. C., … Putnam, J. B. (2014). Accuracy of Fluorodeoxyglucose-Positron Emission Tomography Within the Clinical Practice of the American College of Surgeons Oncology Group Z4031 Trial to Diagnose Clinical Stage I Non-Small Cell Lung Cancer. ANNALS OF THORACIC SURGERY, 97(4), 1142–48.
- Consensus definitions to promote an evidence-based approach to management of the pleural space. A collaborative proposal by ESTS, AATS, STS, and GTSC
  Brunelli, A., Beretta, E., Cassivi, S. D., Cerfolio, R. J., Detterbeck, F., Kiefer, T., … Varela, G. (2011). Consensus definitions to promote an evidence-based approach to management of the pleural space. A collaborative proposal by ESTS, AATS, STS, and GTSC. EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 40(2), 291–97.
- Should buttresses and sealants be used to manage pulmonary parenchymal air leaks?
  Singhal, S., & Shrager, J. B. (2010). Should buttresses and sealants be used to manage pulmonary parenchymal air leaks? JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 140(6), 1220–25.
- An Observational Study of Circulating Tumor Cells and F-18-FDG PET Uptake in Patients with Treatment-Naive Non-Small Cell Lung Cancer
  Nair, V. S., Keu, K. V., Luttgen, M. S., Kolatkar, A., Vasanawala, M., Kuschner, W., … Kuhn, P. (2013). An Observational Study of Circulating Tumor Cells and F-18-FDG PET Uptake in Patients with Treatment-Naive Non-Small Cell Lung Cancer. PLOS ONE, 8(7).
- Malignant pleural mesothelioma and the Society of Thoracic Surgeons Database: an analysis of surgical morbidity and mortality.
  Burt, B. M., Cameron, R. B., Mollberg, N. M., Kosinski, A. S., Schipper, P. H., Shrager, J. B., & Vigneswaran, W. T. (2014). Malignant pleural mesothelioma and the Society of Thoracic Surgeons Database: an analysis of surgical morbidity and mortality. Journal of Thoracic and Cardiovascular Surgery, 148(1), 30–35.
- Thoracoscopic lobectomy is associated with acceptable morbidity and mortality in patients with predicted postoperative forced expiratory volume in 1 second or diffusing capacity for carbon monoxide less than 40% of normal.
  Burt, B. M., Kosinski, A. S., Shrager, J. B., Onaitis, M. W., & Weigel, T. (2014). Thoracoscopic lobectomy is associated with acceptable morbidity and mortality in patients with predicted postoperative forced expiratory volume in 1 second or diffusing capacity for carbon monoxide less than 40% of normal. Journal of Thoracic and Cardiovascular Surgery, 148(1), 19-?
- Circulating Tumor Microemboli Diagnostics for Patients with Non-Small-Cell Lung Cancer
  Carlsson, A., Nair, V. S., Luttgen, M. S., Keu, K. V., Horng, G., Vasanawala, M., … Gambhir, S. S. (2014). Circulating Tumor Microemboli Diagnostics for Patients with Non-Small-Cell Lung Cancer. JOURNAL OF THORACIC ONCOLOGY, 9(8), 1111–19.
- Chronic cutaneous chest wall fistula and gallstone empyema due to retained gallstones.
  Gaster, R. S., Berger, A. J., Ahmadi-Kashani, M., Shrager, J. B., & Lee, G. K. (2014). Chronic cutaneous chest wall fistula and gallstone empyema due to retained gallstones. BMJ Case Reports, 2014.
- Lung Volume Reduction After Stereotactic Ablative Radiation Therapy of Lung Tumors: Potential Application to Emphysema
  Binkley, M. S., Shrager, J. B., Leung, A. N., Popat, R., Trakul, N., Atwood, T. F., … Loo, B. W. (2014). Lung Volume Reduction After Stereotactic Ablative Radiation Therapy of Lung Tumors: Potential Application to Emphysema. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 90(1), 216–23.
- Failure to Isolate the Right Lung with an EZ-Blocker.
  Obaidi, R. A., O'Hear, K. E., Kulkarni, V. N., Brodsky, J. B., & Shrager, J. B. (2014). Failure to Isolate the Right Lung with an EZ-Blocker. A & A Case Reports, 3(8), 110–11.
- Sequential bilateral lung isolation with a single bronchial blocker.
  Brodsky, J. B., Tzabazis, A., Basarb-Tung, J., & Shrager, J. B. (2013). Sequential bilateral lung isolation with a single bronchial blocker. A & A Case Reports, 1(1), 17–18.
- The JAK-STAT Pathway Is Critical in Ventilator-Induced Diaphragm Dysfunction.
  Tang, H., Smith, I. J., Hussain, S. N. A., Goldberg, P., Lee, M., Sugiarto, S., … Shrager, J. B. (2015). The JAK-STAT Pathway Is Critical in Ventilator-Induced Diaphragm Dysfunction. Molecular Medicine , 20(1), 579–89.
- Lung volume reduction after stereotactic ablative radiation therapy of lung tumors: potential application to emphysema.
  Binkley, M. S., Shrager, J. B., Leung, A. N., Popat, R., Trakul, N., Atwood, T. F., … Loo, B. W. (2014). Lung volume reduction after stereotactic ablative radiation therapy of lung tumors: potential application to emphysema. International Journal of Radiation Oncology, Biology, Physics, 90(1), 216–23.
- Diameter of Solid Tumor Component Alone Should be Used to Establish T Stage in Lung Adenocarcinoma.
  Burt, B. M., Leung, A. N., Yanagawa, M., Chen, W., Groth, S. S., Hoang, C. D., … Shrager, J. B. (2015). Diameter of Solid Tumor Component Alone Should be Used to Establish T Stage in Lung Adenocarcinoma. Annals of Surgical Oncology, 22, 1318–23.
- Ex Vivo Expansion and In Vivo Self-Renewal of Human Muscle Stem Cells
  Charville, G. W., Cheung, T. H., Yoo, B., Santos, P. J., Lee, G. K., Shrager, J. B., & Rando, T. A. (2015). Ex Vivo Expansion and In Vivo Self-Renewal of Human Muscle Stem Cells. STEM CELL REPORTS, 5(4), 621–32.
- Diameter of Solid Tumor Component Alone Should be Used to Establish T Stage in Lung Adenocarcinoma
  Burt, B. M., Leung, A. N., Yanagawa, M., Chen, W., Groth, S. S., Hoang, C. D., … Shrager, J. B. (2015). Diameter of Solid Tumor Component Alone Should be Used to Establish T Stage in Lung Adenocarcinoma. ANNALS OF SURGICAL ONCOLOGY, 22, S1318–S1323.
- Pruritus as a Paraneoplastic Symptom of Thymoma
  Padda, S. K., Shrager, J. B., Riess, J. W., Pagtama, J. Y., Tisch, A. J. H., Kwong, B. Y., … Wakelee, H. A. (2015). Pruritus as a Paraneoplastic Symptom of Thymoma. JOURNAL OF THORACIC ONCOLOGY, 10(11), E110–E112.
- The Prevention and Management of Air Leaks Following Pulmonary Resection.
  Burt, B. M., & Shrager, J. B. (2015). The Prevention and Management of Air Leaks Following Pulmonary Resection. Thoracic Surgery Clinics, 25(4), 411–19.
- CRISPR/Cas-mediated genome editing to treat EGFR-mutant lung cancer: apersonalized molecular surgical therapy
  Tang, H., & Shrager, J. B. (2016). CRISPR/Cas-mediated genome editing to treat EGFR-mutant lung cancer: apersonalized molecular surgical therapy. EMBO MOLECULAR MEDICINE, 8(2), 83–85.
- Time course and predictive factors for lung volume reduction following stereotactic ablative radiotherapy (SABR) of lung tumors.
  Binkley, M. S., Shrager, J. B., Chaudhuri, A., Popat, R., Maxim, P. G., Shultz, D. B., … Loo, B. W. (2016). Time course and predictive factors for lung volume reduction following stereotactic ablative radiotherapy (SABR) of lung tumors. Radiation Oncology , 11(1), 40-?
- Time course and predictive factors for lung volume reduction following stereotactic ablative radiotherapy (SABR) of lung tumors
  Binkley, M. S., Shrager, J. B., Chaudhuri, A., Popat, R., Maxim, P. G., Shultz, D. B., … Loo, B. W. (2016). Time course and predictive factors for lung volume reduction following stereotactic ablative radiotherapy (SABR) of lung tumors. RADIATION ONCOLOGY, 11.
- Integrated digital error suppression for improved detection of circulating tumor DNA
  Newman, A. M., Lovejoy, A. F., Klass, D. M., Kurtz, D. M., Chabon, J. J., Scherer, F., … Alizadeh, A. A. (2016). Integrated digital error suppression for improved detection of circulating tumor DNA. NATURE BIOTECHNOLOGY, 34(5), 547–55.
- Thoracoscopic Resection of a Symptomatic, Congenital Rib Synostosis.
  Brewer, Z. E., Vokic, N. C., & Shrager, J. B. (2016). Thoracoscopic Resection of a Symptomatic, Congenital Rib Synostosis. Annals of Thoracic Surgery, 101(4), 1596–98.
- Concordant and Discordant EGFR Mutations in Patients With Multifocal Adenocarcinomas: Implications for EGFR-Targeted Therapy.
  Chuang, J. C., Shrager, J. B., Wakelee, H. A., & Neal, J. W. (2016). Concordant and Discordant EGFR Mutations in Patients With Multifocal Adenocarcinomas: Implications for EGFR-Targeted Therapy. Clinical Therapeutics, 38(7), 1567–76.
- An artificial niche preserves the quiescence of muscle stem cells and enhances their therapeutic efficacy.
  Quarta, M., Brett, J. O., DiMarco, R., de Morree, A., Boutet, S. C., Chacon, R., … Rando, T. A. (2016). An artificial niche preserves the quiescence of muscle stem cells and enhances their therapeutic efficacy. Nature Biotechnology, 34(7), 752–59.
- Invited Commentary.
  Shrager, J. (2016). Invited Commentary. Annals of Thoracic Surgery, 101(6), 2146–47.
- Molecular profiling of single circulating tumor cells from lung cancer patients
  Park, S.-M., Wong, D. J., Ooi, C. C., Kurtz, D. M., Vermesh, O., Aalipour, A., … Gambhir, S. S. (2016). Molecular profiling of single circulating tumor cells from lung cancer patients. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 113(52), E8379–E8386.
- Determinants of Complete Resection of Thymoma by Minimally Invasive and Open Thymectomy: Analysis of an International Registry.
  Burt, B. M., Yao, X., Shrager, J., Antonicelli, A., Padda, S., Reiss, J., … Scott, W. (2016). Determinants of Complete Resection of Thymoma by Minimally Invasive and Open Thymectomy: Analysis of an International Registry. Journal of Thoracic Oncology .
- Pulmonary function after lung tumor stereotactic ablative radiotherapy depends on regional ventilation within irradiated lung.
  Binkley, M. S., King, M. T., Shrager, J. B., Bush, K., Chaudhuri, A. A., Popat, R., … Loo, B. W. (2017). Pulmonary function after lung tumor stereotactic ablative radiotherapy depends on regional ventilation within irradiated lung. Radiotherapy and Oncology , 123(2), 270–75.
- Video-assisted thoracoscopic diaphragm plication using a running suture technique is durable and effective.
  Demos, D. S., Berry, M. F., Backhus, L. M., & Shrager, J. B. (2016). Video-assisted thoracoscopic diaphragm plication using a running suture technique is durable and effective. Journal of Thoracic and Cardiovascular Surgery.
- Determinants of Complete Resection of Thymoma by Minimally Invasive and Open Thymectomy: Analysis of an International Registry
  Burt, B. M., Yao, X., Shrager, J., Antonicelli, A., Padda, S., Reiss, J., … Scott, W. (2017). Determinants of Complete Resection of Thymoma by Minimally Invasive and Open Thymectomy: Analysis of an International Registry. JOURNAL OF THORACIC ONCOLOGY, 12(1), 129–36.
- Predictive radiogenomics modeling of EGFR mutation status in lung cancer
  Gevaert, O., Echegaray, S., Khuong, A., Hoang, C. D., Shrager, J. B., Jensen, K. C., … Leung, A. N. (2017). Predictive radiogenomics modeling of EGFR mutation status in lung cancer. SCIENTIFIC REPORTS, 7.
- Validating a dipstick method for detecting recent smoking
  Gariti, P., Rosenthal, D. I., Lindell, K., Hansen-Flaschen, J., Shrager, J., Lipkin, C., … Kaiser, L. R. (2002). Validating a dipstick method for detecting recent smoking. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 11(10), 1123–25.
- Bioenergetic adaptation of individual human diaphragmatic myofibers to severe COPD
  Levine, S., Gregory, C., Nguyen, T., Shrager, J., Kaiser, L., Rubinstein, N., & Dudley, G. (2002). Bioenergetic adaptation of individual human diaphragmatic myofibers to severe COPD. JOURNAL OF APPLIED PHYSIOLOGY, 92(3), 1205–13.
- Prediction of EGFR and KRAS mutation in non-small cell lung cancer using quantitative 18F FDG-PET/CT metrics.
  Minamimoto, R., Jamali, M., Gevaert, O., Echegaray, S., Khuong, A., Hoang, C. D., … Quon, A. (2017). Prediction of EGFR and KRAS mutation in non-small cell lung cancer using quantitative 18F FDG-PET/CT metrics. Oncotarget.
- Improving Care With a Portfolio of Physician-Led Cancer Quality Measures at an Academic Center
  Porter, J. B. (2017). Improving Care With a Portfolio of Physician-Led Cancer Quality Measures at an Academic Center. Improving Care With a Portfolio of Physician-Led Cancer Quality Measures at an Academic Center, 13(8), e673–e682.
- Early detection of molecular residual disease in localized lung cancer by circulating tumor DNA profiling.
  Chaudhuri, A. A., Chabon, J. J., Lovejoy, A. F., Newman, A. M., Stehr, H., Azad, T. D., … Diehn, M. (2017). Early detection of molecular residual disease in localized lung cancer by circulating tumor DNA profiling. Cancer Discovery.
- Non-Small Cell Lung Cancer Radiogenomics Map Identifies Relationships between Molecular and Imaging Phenotypes with Prognostic Implications.
  Zhou, M., Leung, A., Echegaray, S., Gentles, A., Shrager, J. B., Jensen, K. C., … Gevaert, O. (2018). Non-Small Cell Lung Cancer Radiogenomics Map Identifies Relationships between Molecular and Imaging Phenotypes with Prognostic Implications. Radiology, 286(1), 307–15.
- Effect of Perioperative Gabapentin on Postoperative Pain Resolution and Opioid Cessation in a Mixed Surgical Cohort: A Randomized Clinical Trial.
  Hah, J., Mackey, S. C., Schmidt, P., McCue, R., Humphreys, K., Trafton, J., … Carroll, I. (2017). Effect of Perioperative Gabapentin on Postoperative Pain Resolution and Opioid Cessation in a Mixed Surgical Cohort: A Randomized Clinical Trial. JAMA Surgery.
- Fdg Pet-CT Suvmax And Circulating Tumor Microemboli Identify Recurrence In Patients With Non-Small Cell Lung Cancer
  Nair, V. S., Carlsson, F., Carlsson, A., Jamali, M., Keu, K.-V., Vasanawala, M., … Kuhn, P. (2017). Fdg Pet-CT Suvmax And Circulating Tumor Microemboli Identify Recurrence In Patients With Non-Small Cell Lung Cancer. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE. AMER THORACIC SOC.
- Developing a non-invasive, diagnostic test for stage I non-small cell lung cancer using circulating tumor cells.
  Luttgen, M. S., Keu, K. V., Nair, V. S., Horng, G., Vasanawala, M., Kolatkar, A., … Gambhir, S. S. (2013). Developing a non-invasive, diagnostic test for stage I non-small cell lung cancer using circulating tumor cells. CANCER RESEARCH. AMER ASSOC CANCER RESEARCH.
- Stage I Lung Adenocarcinoma Tumor Density And Contour Do Not Predict Circulating Tumor Cell Burden
  Nair, V. S., Luttgen, M., Keu, K., Jamali, M., Horng, G., Vasanawala, M., … Gambhir, S. S. (2014). Stage I Lung Adenocarcinoma Tumor Density And Contour Do Not Predict Circulating Tumor Cell Burden. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE. AMER THORACIC SOC.
- Induction therapy for locally advanced distal esophageal adenocarcinoma: Is radiation Always necessary?
  Liou, D. Z., Backhus, L. M., Lui, N. S., Shrager, J. B., & Berry, M. F. (2018). Induction therapy for locally advanced distal esophageal adenocarcinoma: Is radiation Always necessary? The Journal of Thoracic and Cardiovascular Surgery.
- Comparison of Circulating Tumor DNA Analysis and Surveillance Imaging After Treatment for Localized Lung Cancer
  Chaudhuri, A. A., Chabon, J. J., Lovejoy, A. F., Newman, A., Stehr, H., Azad, T. D., … Diehn, M. (2017). Comparison of Circulating Tumor DNA Analysis and Surveillance Imaging After Treatment for Localized Lung Cancer. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. ELSEVIER SCIENCE INC.
- Ultrasensitive Detection of Circulating Tumor DNA in Non-Small Cell Lung Cancer by Deep Sequencing
  Diehn, M., Bratman, S. V., Newman, A. M., Neal, J. W., Wakelee, H. A., Merritt, R. E., … Alizadeh, A. (2014). Ultrasensitive Detection of Circulating Tumor DNA in Non-Small Cell Lung Cancer by Deep Sequencing. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. ELSEVIER SCIENCE INC.
- Circulating Tumor DNA Concentrations Reflect Metabolic Tumor Volume in NSCLC
  Modlin, L. A., Bratman, S. V., Newman, A. M., Eclov, N. C. W., Neal, J. W., Wakelee, H. A., … Diehn, M. (2014). Circulating Tumor DNA Concentrations Reflect Metabolic Tumor Volume in NSCLC. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. ELSEVIER SCIENCE INC.
- Circulating Tumor DNA Detects Minimal Residual Disease and Predicts Outcome in Localized Lung Cancer
  Chaudhuri, A., Lovejoy, A., Chabon, J., Newman, A., Stehr, H., Say, C., … Diehn, M. (2017). Circulating Tumor DNA Detects Minimal Residual Disease and Predicts Outcome in Localized Lung Cancer. JOURNAL OF THORACIC ONCOLOGY. ELSEVIER SCIENCE INC.
- Noninvasive and Ultrasensitive Quantitation of Circulating Tumor DNA by Hybrid Capture and Deep Sequencing
  Bratman, S. V., Newman, A. M., To, J., Wynne, J. F., Neal, J. W., Wakelee, H., … Diehn, M. (2013). Noninvasive and Ultrasensitive Quantitation of Circulating Tumor DNA by Hybrid Capture and Deep Sequencing. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. ELSEVIER SCIENCE INC.
- Clinically relevant interactions between micro-RNAs and genes in malignant mesothelioma characterized by an integrated analysis
  Hoang, C. D., Gentles, A., Xu, Y., Plevritis, S. K., Merritt, R., Whyte, R., … Kratzke, R. A. (2011). Clinically relevant interactions between micro-RNAs and genes in malignant mesothelioma characterized by an integrated analysis. CANCER RESEARCH. AMER ASSOC CANCER RESEARCH.
- INTEGRATED ANALYSIS OF MICRO-RNAS AND GENES IN MALIGNANT MESOTHELIOMA
  Hoang, C. D., Gentles, A., Xu, Y., Plevritis, S., Merritt, R. E., Whyte, R. I., … Kratzke, R. A. (2011). INTEGRATED ANALYSIS OF MICRO-RNAS AND GENES IN MALIGNANT MESOTHELIOMA. JOURNAL OF THORACIC ONCOLOGY. LIPPINCOTT WILLIAMS & WILKINS.
- AAV Capsid Evolution for Enhanced Antibody Delivery to Human Skeletal Muscle for Use in Next-Generation HIV Vaccines and Muscle Gene Therapies
  Paulk, N. K., Charville, G., Maguire, K., Pekrun, K., Zhang, Y., Tiffany, M., … Kay, M. A. (2016). AAV Capsid Evolution for Enhanced Antibody Delivery to Human Skeletal Muscle for Use in Next-Generation HIV Vaccines and Muscle Gene Therapies. MOLECULAR THERAPY. NATURE PUBLISHING GROUP.
- Evolved AAV Capsids for Intramuscular Passive Vaccine Administration to Human Skeletal Muscle
  Paulk, N. K., Pekrun, K., Charville, G., Maguire-Nguyen, K., Xu, J., Wosczyna, M., … Kay, M. A. (2017). Evolved AAV Capsids for Intramuscular Passive Vaccine Administration to Human Skeletal Muscle. MOLECULAR THERAPY. CELL PRESS.
- Smad3 initiates oxidative stress and proteolysis that underlies diaphragm dysfunction during mechanical ventilation
  Tang, H., Kennedy, C. L., Lee, M., Gao, Y., Xia, H., Olguin, F., … Shrager, J. B. (2017). Smad3 initiates oxidative stress and proteolysis that underlies diaphragm dysfunction during mechanical ventilation. SCIENTIFIC REPORTS, 7, 14530.
- Bioengineered constructs combined with exercise enhance stem cell-mediated treatment of volumetric muscle loss
  Quarta, M., Cromie, M., Chacon, R., Blonigan, J., Garcia, V., Akimenko, I., … Rando, T. A. (2017). Bioengineered constructs combined with exercise enhance stem cell-mediated treatment of volumetric muscle loss. NATURE COMMUNICATIONS, 8, 15613.
- ENERGY METABOLISM IN LUNG ADENOCARCINOMA
  Hoang, C., Xu, Y., Shi, Z., Lin, Y., Merritt, R. E., Shrager, J., … Wakelee, H. A. (2013). ENERGY METABOLISM IN LUNG ADENOCARCINOMA. JOURNAL OF THORACIC ONCOLOGY. LIPPINCOTT WILLIAMS & WILKINS.
- PRURITUS AS A PARANEOPLASTIC SYMPTOM OF THYMOMA
  Padda, S. K., Pagtama, J. Y., Tisch, A. H., Neal, J. W., Riess, J. W., Loo, B. W., … Wakelee, H. A. (2014). PRURITUS AS A PARANEOPLASTIC SYMPTOM OF THYMOMA. JOURNAL OF THORACIC ONCOLOGY, 9(10), S240–S241.
- Computed Tomography (CT) Characteristics Associated with the Proposed IASLC/ITMIG TNM Pathologic Staging System for Thymoma
  Padda, S. K., Terrone, D., Khuong, A., Tian, L., Neal, J. W., Riess, J. W., … Wakelee, H. A. (2015). Computed Tomography (CT) Characteristics Associated with the Proposed IASLC/ITMIG TNM Pathologic Staging System for Thymoma. JOURNAL OF THORACIC ONCOLOGY, 10(9), S196.
- COMPUTED TOMOGRAPHY (CT) CHARACTERISTICS ASSOCIATED WITH MASAOKA-KOGA PATHOLOGIC STAGE IN THYMOMA
  Padda, S. K., Terrone, D., Khuong, A., Tian, L., Neal, J. W., Riess, J. W., … Wakelee, H. A. (2014). COMPUTED TOMOGRAPHY (CT) CHARACTERISTICS ASSOCIATED WITH MASAOKA-KOGA PATHOLOGIC STAGE IN THYMOMA. JOURNAL OF THORACIC ONCOLOGY, 9(10), S222.
- VIETNAMESE NON-SMALL CELL LUNG CANCER PATIENTS IN CALIFORNIA: MOLECULAR PROFILES AND CLINICAL CHARACTERISTICS
  Nguyen, K.-S. H., Das, M., Ramchandran, K., Shrager, J., Merritt, R. E., Hoang, C., … Neal, J. W. (2013). VIETNAMESE NON-SMALL CELL LUNG CANCER PATIENTS IN CALIFORNIA: MOLECULAR PROFILES AND CLINICAL CHARACTERISTICS. JOURNAL OF THORACIC ONCOLOGY. LIPPINCOTT WILLIAMS & WILKINS.
- Noninvasive and ultrasensitive quantitation of circulating tumor DNA by hybrid capture and deep sequencing.
  Bratman, S. V., Newman, A. M., To, J., Wynne, J. F., Neal, J. W., Wakelee, H. A., … Alizadeh, A. A. (2014). Noninvasive and ultrasensitive quantitation of circulating tumor DNA by hybrid capture and deep sequencing. JOURNAL OF CLINICAL ONCOLOGY, 32(15).
- Circulating Tumor DNA Detects Residual Disease and Anticipates Tumor Progression Earlier Than CT Imaging
  Chaudhuri, A. A., Chabon, J. J., Lovejoy, A. F., Newman, A. M., Stehr, H., Azad, T. D., … Diehn, M. (2017). Circulating Tumor DNA Detects Residual Disease and Anticipates Tumor Progression Earlier Than CT Imaging. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. ELSEVIER SCIENCE INC.
- Computed Tomography Features associated With the Eighth Edition TNM Stage Classification for Thymic Epithelial Tumors
  Padda, S. K., Terrone, D., Tian, L., Khuong, A., Neal, J. W., Riess, J. W., … Wakelee, H. A. (2018). Computed Tomography Features associated With the Eighth Edition TNM Stage Classification for Thymic Epithelial Tumors. JOURNAL OF THORACIC IMAGING, 33(3), 176–83.
- Survival and risk factors for progression after resection of the dominant tumor in multifocal, lepidic-type pulmonary adenocarcinoma
  Gao, R. W., Berry, M. F., Kunder, C. A., Khuong, A. A., Wakelee, H., Neal, J. W., … Shrager, J. B. (2017). Survival and risk factors for progression after resection of the dominant tumor in multifocal, lepidic-type pulmonary adenocarcinoma. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 154(6), 2092-+.
- Presence of Even a Small Ground-Glass Component in Lung Adenocarcinoma Predicts Better Survival
  Berry, M. F., Gao, R., Kunder, C. A., Backhus, L., Khuong, A., Kadoch, M., … Shrager, J. (2018). Presence of Even a Small Ground-Glass Component in Lung Adenocarcinoma Predicts Better Survival. CLINICAL LUNG CANCER, 19(1), E47–E51.
- Effect of EGFR Mutations on Survival in Patients following Surgical Resection of Lung Adenocarcinoma
  Laidlaw, G., Gao, R., Ayers, K., Backhus, L., Berry, M., & Shrager, J. (2017). Effect of EGFR Mutations on Survival in Patients following Surgical Resection of Lung Adenocarcinoma. JOURNAL OF THORACIC ONCOLOGY, 12(1), S751.
- Intraoperative costs of video-assisted thoracoscopic lobectomy can be dramatically reduced without compromising outcomes
  Richardson, M. T., Backhus, L. M., Berry, M. F., Vail, D. G., Ayers, K. C., Benson, J. A., … Shrager, J. B. (2018). Intraoperative costs of video-assisted thoracoscopic lobectomy can be dramatically reduced without compromising outcomes. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 155(3), 1267-+.
- GFPT2-expressing cancer-associated fibroblasts mediate metabolic reprogramming in human lung adenocarcinoma.
  Zhang, W., Bouchard, G., Yu, A., Shafiq, M., Jamali, M., Shrager, J. B., … Plevritis, S. K. (2018). GFPT2-expressing cancer-associated fibroblasts mediate metabolic reprogramming in human lung adenocarcinoma. Cancer Research.
- Paraneoplastic Syndromes and Thymic Malignancies: An Examination of the International Thymic Malignancy Interest Group Retrospective Database
  Padda, S. K., Yao, X., Antonicelli, A., Riess, J. W., Shang, Y., Shrager, J. B., … Badve, S. S. (2018). Paraneoplastic Syndromes and Thymic Malignancies: An Examination of the International Thymic Malignancy Interest Group Retrospective Database. JOURNAL OF THORACIC ONCOLOGY, 13(3), 436–46.
- The Signaling Network Resulting in Ventilator-induced Diaphragm Dysfunction.
  Tang, H., & Shrager, J. B. (2018). The Signaling Network Resulting in Ventilator-induced Diaphragm Dysfunction. American Journal of Respiratory Cell and Molecular Biology.
- Minimally Invasive Thymectomy and Lung Volume Reduction in a Patient with Myasthenia Gravis.
  Salna, M., Kidambi, S., Sampson, J., & Shrager, J. B. (2018). Minimally Invasive Thymectomy and Lung Volume Reduction in a Patient with Myasthenia Gravis. The Annals of Thoracic Surgery.
- Stage IB: To give (chemo), or not to give? That is the question
  Shrager, J. B. (2018). Stage IB: To give (chemo), or not to give? That is the question. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 155(3), 1206.
- Synchronous primary lung adenocarcinomas harboring distinct MET Exon 14 splice site mutations.
  Wang, S. X., Lei, L., Guo, H. H., Shrager, J., Kunder, C. A., & Neal, J. W. (2018). Synchronous primary lung adenocarcinomas harboring distinct MET Exon 14 splice site mutations. Lung Cancer (Amsterdam, Netherlands), 122, 187–91.
- Bioengineered Viral Platform for Intramuscular Passive Vaccine Delivery to Human Skeletal Muscle.
  Paulk, N. K., Pekrun, K., Charville, G. W., Maguire-Nguyen, K., Wosczyna, M. N., Xu, J., … Kay, M. A. (2018). Bioengineered Viral Platform for Intramuscular Passive Vaccine Delivery to Human Skeletal Muscle. Molecular Therapy. Methods & Clinical Development, 10, 144–55.
- Regional Ventilation Predicts Change in Pulmonary Function After Stereotactic Ablative Radiation Therapy of Lung Tumors
  Binkley, M. S., King, M., Bush, K., Shrager, J. B., Chaudhuri, A. A., Popat, R., … Loo, B. W. (2016). Regional Ventilation Predicts Change in Pulmonary Function After Stereotactic Ablative Radiation Therapy of Lung Tumors. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 96(2), E456–E457.
- Time Course and Predictive Factors for Lung Volume Reduction Following Stereotactic Ablative Radiation Therapy (SABR) of Lung Tumors
  Binkley, M. S., Shrager, J. B., Chaudhuri, A., Popat, R., Maxim, P. G., Shultz, D. B., … Loo, B. W. (2015). Time Course and Predictive Factors for Lung Volume Reduction Following Stereotactic Ablative Radiation Therapy (SABR) of Lung Tumors. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 93(3), E424.
- Imaging Based Parameters Associated With Disease Progression of Early-Stage NSCLC Treated With Surgical Resection
  Wang, A., von Eyben, R., Loo, B. W., Diehn, M., Shrager, J. B., Maxim, P. G., … Shultz, D. B. (2015). Imaging Based Parameters Associated With Disease Progression of Early-Stage NSCLC Treated With Surgical Resection. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 93(3), E414.
- Lung Volume Reduction After Stereotactic Ablative Radiation Therapy of Lung Tumors: Potential Application to Emphysema
  Binkley, M. S., Shrager, J. B., Trakul, N., Leung, A. N., Popat, R., Atwood, T. F., … Loo, B. W. (2013). Lung Volume Reduction After Stereotactic Ablative Radiation Therapy of Lung Tumors: Potential Application to Emphysema. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 87(2), S545–S546.
- POSTPARTUM DIAGNOSIS OF CARDIAC PARAGANGLIOMA: A CASE REPORT
  Berona, K., Joshi, R., Woo, Y. J., & Shrager, J. (2018). POSTPARTUM DIAGNOSIS OF CARDIAC PARAGANGLIOMA: A CASE REPORT. JOURNAL OF EMERGENCY MEDICINE, 55(4), E101–E105.
- A radiogenomic dataset of non-small cell lung cancer.
  Bakr, S., Gevaert, O., Echegaray, S., Ayers, K., Zhou, M., Shafiq, M., … Napel, S. (2018). A radiogenomic dataset of non-small cell lung cancer. Scientific Data, 5, 180202.
- Small Molecule Derived From Carboxyethylpyrrole Protein Adducts Promotes Angiogenesis in a Mouse Model of Peripheral Arterial Disease.
  Hou, L., Yang, G., Tang, S., Alcazar, C., Joshi, P., Strassberg, Z., … Huang, N. F. (2018). Small Molecule Derived From Carboxyethylpyrrole Protein Adducts Promotes Angiogenesis in a Mouse Model of Peripheral Arterial Disease. Journal of the American Heart Association, 7(18), e009234.
- Genomic Profiling of Bronchoalveolar Lavage Fluid in Patients with Non-Small Cell Lung Cancer
  Nair, V. S., Li, A. B.-H., Stehr, H., Chabon, J., Chaudhuri, A., Zhou, L., … Diehn, M. (2018). Genomic Profiling of Bronchoalveolar Lavage Fluid in Patients with Non-Small Cell Lung Cancer. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 197.
- Examination of Optimal Timing of Post-Surgical Surveillance for Early Stage Lung Cancer Patients and Association with Outcomes
  Colwell, E., Bhandari, P., Benson, J., He, H., Lui, N., Berry, M., … Backhus, L. (2018). Examination of Optimal Timing of Post-Surgical Surveillance for Early Stage Lung Cancer Patients and Association with Outcomes. JOURNAL OF THORACIC ONCOLOGY, 13(10), S819.
- Factors Associated With Acute Pain Estimation, Postoperative Pain Resolution, Opioid Cessation, and Recovery: Secondary Analysis of a Randomized Clinical Trial.
  Hah, J. M., Cramer, E., Hilmoe, H., Schmidt, P., McCue, R., Trafton, J., … Carroll, I. (2019). Factors Associated With Acute Pain Estimation, Postoperative Pain Resolution, Opioid Cessation, and Recovery: Secondary Analysis of a Randomized Clinical Trial. JAMA Network Open, 2(3), e190168.
- Using Tissue Gene Expression To Predict Survival Following 'curative' Surgical Resection In Lung Adenocarcinoma
  Shafiq, M., Zhang, W., Gentles, A., Ayers, K., Nair, V. S., Shrager, J., … Plevritis, S. (2017). Using Tissue Gene Expression To Predict Survival Following 'curative' Surgical Resection In Lung Adenocarcinoma. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 195.
- Randomized Trial of Thymectomy in Myasthenia Gravis
  Shrager, J. B. (2016). Randomized Trial of Thymectomy in Myasthenia Gravis. NEW ENGLAND JOURNAL OF MEDICINE, 375(20), 2005–6.
- Endobronchial valves in a highly parsed emphysema population
  Shrager, J. B. (2015). Endobronchial valves in a highly parsed emphysema population. LANCET, 386(9998), 1022–23.
- Proteomic analysis for detection of NSCLC: Results of ACOSOG Z4031.
  Harpole, D., Ballman, K. V., Oberg, A. L., Whiteley, G., Cerfolio, R., Keenan, R., … Putnam, J. B. (2011). Proteomic analysis for detection of NSCLC: Results of ACOSOG Z4031. JOURNAL OF CLINICAL ONCOLOGY, 29(15).
- ENDOBRONCHIAL ULTRASOUND IS HIGHLY EFFECTIVE FOR THE DIAGNOSIS OF LUNG CARCINOMA AND ENABLES EGFR MUTATION ANALYSIS
  Merritt, R. E., Hoang, C. D., Whyte, R. I., & Shrager, J. B. (2011). ENDOBRONCHIAL ULTRASOUND IS HIGHLY EFFECTIVE FOR THE DIAGNOSIS OF LUNG CARCINOMA AND ENABLES EGFR MUTATION ANALYSIS. JOURNAL OF THORACIC ONCOLOGY, 6(6), S853–S854.
- FDG-PET avidity negatively impacts survival in pStage I NSCLC in the ACOSOG Z4031 trial.
  Grogan, E. L., Deppen, S. A., Chen, H., Ballman, K. V., Verdial, F. C., Aldrich, M. C., … Putnam, J. B. (2013). FDG-PET avidity negatively impacts survival in pStage I NSCLC in the ACOSOG Z4031 trial. CANCER RESEARCH, 73(8).
- Accuracy of FDG-PET to diagnose lung cancer in the ACOSOG Z4031 trial.
  Grogan, E. L., Deppen, S. A., Ballman, K. V., Andrade, G. M., Verdail, F. C., Aldrich, M. C., … Putnam, J. B. (2012). Accuracy of FDG-PET to diagnose lung cancer in the ACOSOG Z4031 trial. JOURNAL OF CLINICAL ONCOLOGY, 30(15).
- The Society of Thoracic Surgeons Practice Guideline on the Prophylaxis and Management of Atrial Fibrillation Associated With General Thoracic Surgery: Executive Summary
  Fernando, H. C., Jaklitsch, M. T., Walsh, G. L., Tisdale, J. E., Bridges, C. D., Mitchell, J. D., & Shrager, J. B. (2011). The Society of Thoracic Surgeons Practice Guideline on the Prophylaxis and Management of Atrial Fibrillation Associated With General Thoracic Surgery: Executive Summary. ANNALS OF THORACIC SURGERY, 92(3), 1144–52.
- Adjuvant radiotherapy for completely resected stage II thymoma
  Berman, A. T., Singhal, S., Su, S., Kucharczuk, J. C., Cooper, J. D., Shrager, J., … Rengan, R. (2009). Adjuvant radiotherapy for completely resected stage II thymoma. JOURNAL OF THORACIC ONCOLOGY, 4(9), S937–S938.
- Comparative study of anterior and posterior approaches to superior sulcus tumors
  Shrager, J. B., Nathan, D., Hoang, C. D., Kurichi, J. E., Kucharczuk, J. C., & Kaiser, L. R. (2009). Comparative study of anterior and posterior approaches to superior sulcus tumors. JOURNAL OF THORACIC ONCOLOGY, 4(9), S302.
- Spontaneous Chylopericardium: Delineation of the Underlying Anatomic Pathology by CT Lymphangiography
  Itkin, M., Swe, N. M., Shapiro, S. E., & Shrager, J. B. (2009). Spontaneous Chylopericardium: Delineation of the Underlying Anatomic Pathology by CT Lymphangiography. ANNALS OF THORACIC SURGERY, 87(5), 1595–97.
- Cost reduction in video-assisted thoracoscopic lobectomy
  Richardson, M. T., & Shrager, J. B. (2019). Cost reduction in video-assisted thoracoscopic lobectomy. VIDEO-ASSISTED THORACIC SURGERY, 4.
- Prediction of EGFR and KRAS mutation in non-small cell lung cancer using quantitative 18F FDG-PET/CT metrics.
  Minamimoto, R., Jamali, M., Gevaert, O., Echegaray, S., Khuong, A., Hoang, C. D., … Quon, A. (2017). Prediction of EGFR and KRAS mutation in non-small cell lung cancer using quantitative 18F FDG-PET/CT metrics. Oncotarget, 8(32), 52792–52801.
- CRISPR/Cas-mediated genome editing to treat EGFR-mutant lung cancer: a personalized molecular surgical therapy.
  Tang, H., & Shrager, J. B. (2016). CRISPR/Cas-mediated genome editing to treat EGFR-mutant lung cancer: a personalized molecular surgical therapy. EMBO Molecular Medicine, 8(2), 83–5.
- Improving care with portfolio of physician-led cancer quality measures at an academic center
  Porter, J., Smith, A. S., Winget, M., Rosenthal, E. L., Seshadri, S. B., Vetteth, Y., … Blayney, D. W. (2017). Improving care with portfolio of physician-led cancer quality measures at an academic center. JOURNAL OF CLINICAL ONCOLOGY. AMER SOC CLINICAL ONCOLOGY.
- Clinical and Pathological Variables Influencing Noninvasive Detection of Early Stage Lung Cancer Using Circulating Tumor DNA
  Chabon, J., Chaudhuri, A., Azad, T., Kurtz, D., Stehr, H., Liu, C. L., … Diehn, M. (2017). Clinical and Pathological Variables Influencing Noninvasive Detection of Early Stage Lung Cancer Using Circulating Tumor DNA. JOURNAL OF THORACIC ONCOLOGY. ELSEVIER SCIENCE INC.
- Synchronous primary lung adenocarcinomas harboring distinct MET Exon 14 splice site mutations
  Wang, S. X. Y., Lei, L., Guo, H. H., Shrager, J., Kunder, C. A., & Neal, J. W. (2018). Synchronous primary lung adenocarcinomas harboring distinct MET Exon 14 splice site mutations. LUNG CANCER, 122, 187–91.
- Factors Associated With Acute Pain Estimation, Postoperative Pain Resolution, Opioid Cessation, and Recovery Secondary Analysis of a Randomized Clinical Trial
  Hah, J. M., Cramer, E., Hilmoe, H., Schmidt, P., McCue, R., Trafton, J., … Carroll, I. (2019). Factors Associated With Acute Pain Estimation, Postoperative Pain Resolution, Opioid Cessation, and Recovery Secondary Analysis of a Randomized Clinical Trial. JAMA NETWORK OPEN, 2(3).
- GFPT2-Expressing Cancer-Associated Fibroblasts Mediate Metabolic Reprogramming in Human Lung Adenocarcinoma
  Zhang, W., Bouchard, G., Yu, A., Shafiq, M., Jamali, M., Shrager, J. B., … Plevritis, S. K. (2018). GFPT2-Expressing Cancer-Associated Fibroblasts Mediate Metabolic Reprogramming in Human Lung Adenocarcinoma. CANCER RESEARCH, 78(13), 3445–57.
- Small Molecule Derived From Carboxyethylpyrrole Protein Adducts Promotes Angiogenesis in a Mouse Model of Peripheral Arterial Disease
  Hou, L., Yang, G., Tang, S., Alcazar, C., Joshi, P., Strassberg, Z., … Huang, N. F. (2018). Small Molecule Derived From Carboxyethylpyrrole Protein Adducts Promotes Angiogenesis in a Mouse Model of Peripheral Arterial Disease. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 7(18).
- Minimally Invasive Thymectomy and Lung Volume Reduction in a Patient With Myasthenia Gravis
  Salna, M., Kidambi, S., Sampson, J., & Shrager, J. B. (2018). Minimally Invasive Thymectomy and Lung Volume Reduction in a Patient With Myasthenia Gravis. ANNALS OF THORACIC SURGERY, 106(6), E313–E315.
- Non-Myasthenia Gravis Immune Syndromes and the Thymus Is There a Role for Thymectomy?
  Wightman, S. C., & Shrager, J. B. (2019). Non-Myasthenia Gravis Immune Syndromes and the Thymus Is There a Role for Thymectomy? THORACIC SURGERY CLINICS, 29(2), 215-+.
- A radiogenomic dataset of non-small cell lung cancer
  Bakr, S., Gevaert, O., Echegaray, S., Ayers, K., Zhou, M., Shafiq, M., … Napel, S. (2018). A radiogenomic dataset of non-small cell lung cancer. SCIENTIFIC DATA, 5.
- Bioengineered Viral Platform for Intramuscular Passive Vaccine Delivery to Human Skeletal Muscle
  Paulk, N. K., Pekrun, K., Charville, G. W., Maguire-Nguyen, K., Wosczyna, M. N., Xu, J., … Kay, M. A. (2018). Bioengineered Viral Platform for Intramuscular Passive Vaccine Delivery to Human Skeletal Muscle. MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT, 10, 144–55.
- The Signaling Network Resulting in Ventilator-induced Diaphragm Dysfunction
  Tang, H., & Shrager, J. B. (2018). The Signaling Network Resulting in Ventilator-induced Diaphragm Dysfunction. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 59(4), 417–27.
- Induction therapy for locally advanced distal esophageal adenocarcinoma: Is radiation Always necessary?
  Liou, D. Z., Backhus, L. M., Lui, N. S., Shrager, J. B., & Berry, M. F. (2018). Induction therapy for locally advanced distal esophageal adenocarcinoma: Is radiation Always necessary? JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 155(6), 2697–2705.
- Integrated Bone Marrow and Tumor Radiomics on [18F] FDG Positron Emission Tomography (PET) Augment Stage for Outcome Prediction in Non-Small Cell Lung Cancer
  Mattonen, S. A., Davidzon, G. A., Benson, J. A., Vasanawala, M., Leung, A. N. C., Horng, G. S., … Nair, V. S. (2019). Integrated Bone Marrow and Tumor Radiomics on [18F] FDG Positron Emission Tomography (PET) Augment Stage for Outcome Prediction in Non-Small Cell Lung Cancer. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 199.
- mTORC1 underlies age-related muscle fiber damage and loss by inducing oxidative stress and catabolism
  Tang, H., Inoki, K., Brooks, S. V., Okazawa, H., Lee, M., Wang, J., … Shrager, J. B. (2019). mTORC1 underlies age-related muscle fiber damage and loss by inducing oxidative stress and catabolism. AGING CELL, 18(3).
- Impact of KRAS mutation subtype and concurrent pathogenic mutations on non-small cell lung cancer outcomes.
  Aredo, J. V., Padda, S. K., Kunder, C. A., Han, S. S., Neal, J. W., Shrager, J. B., & Wakelee, H. A. (2019). Impact of KRAS mutation subtype and concurrent pathogenic mutations on non-small cell lung cancer outcomes. Lung Cancer (Amsterdam, Netherlands), 133, 144–50.
- Identifying dynamic EMT states and constructing a proteomic EMT landscape of lung cancer using single cell multidimensional analysis
  Karacosta, L. G., Anchang, B., Kimmey, S., van de Rijn, M., Shrager, J. B., Bendall, S. C., & Plevritis, S. K. (2018). Identifying dynamic EMT states and constructing a proteomic EMT landscape of lung cancer using single cell multidimensional analysis. CANCER RESEARCH. AMER ASSOC CANCER RESEARCH.
- Integrated digital error suppression for noninvasive detection of circulating tumor DNA in NSCLC.
  Newman, A. M., Lovejoy, A. F., Klass, D. M., Kurtz, D. M., Chabon, J. J., Scherer, F., … Diehn, M. (2016). Integrated digital error suppression for noninvasive detection of circulating tumor DNA in NSCLC. JOURNAL OF CLINICAL ONCOLOGY. AMER SOC CLINICAL ONCOLOGY.
- Rapamycin protects aging muscle.
  Tang, H., Shrager, J. B., & Goldman, D. (2019). Rapamycin protects aging muscle. Aging.
- Response to comment on "Impact of KRAS mutation subtype and concurrent pathogenic mutations on non-small cell lung cancer outcomes".
  Aredo, J. V., Padda, S. K., Kunder, C. A., Han, S. S., Neal, J. W., Shrager, J. B., & Wakelee, H. A. (2019). Response to comment on "Impact of KRAS mutation subtype and concurrent pathogenic mutations on non-small cell lung cancer outcomes". Lung Cancer (Amsterdam, Netherlands).
- Endobronchial Valves for Emphysema
  Shrager, J. B. (2011). Endobronchial Valves for Emphysema. NEW ENGLAND JOURNAL OF MEDICINE, 364(4), 382–83.
- Bone Marrow and Tumor Radiomics at 18F-FDG PET/CT: Impact on Outcome Prediction in Non-Small Cell Lung Cancer.
  Mattonen, S. A., Davidzon, G. A., Benson, J., Leung, A. N., Vasanawala, M., Horng, G., … Nair, V. S. (2019). Bone Marrow and Tumor Radiomics at 18F-FDG PET/CT: Impact on Outcome Prediction in Non-Small Cell Lung Cancer. Radiology, 190357.
- Randomized phase II study of adjuvant afatinib for three months versus two years in patients with resected stage I-III EGFR mutant NSCLC.
  Chaft, J. E., Costa, D. B., Muzikansky, A., Shrager, J. B., Lanuti, M., Huang, J., … Neal, J. W. (2019). Randomized phase II study of adjuvant afatinib for three months versus two years in patients with resected stage I-III EGFR mutant NSCLC. JOURNAL OF CLINICAL ONCOLOGY, 37(15).
- Talc Pleurodesis: a Medical, Medicolegal, and Socioeconomic Review.
  Baiu, I., Yevudza, E., & Shrager, J. B. (2019). Talc Pleurodesis: a Medical, Medicolegal, and Socioeconomic Review. The Annals of Thoracic Surgery.
- A Single-Cell Resolution Map of EMT and Drug Resistance States for Evaluating NSCLC Clinical Specimens
  Karacosta, L., Anchang, B., Ignatiadis, N., Kimmey, S., Benson, J., Shrager, J., … Plevritis, S. (2019). A Single-Cell Resolution Map of EMT and Drug Resistance States for Evaluating NSCLC Clinical Specimens. JOURNAL OF THORACIC ONCOLOGY, 14(10), S226–S227.
- Antitumor activity of an engineered decoy receptor targeting CLCF1-CNTFR signaling in lung adenocarcinoma.
  Kim, J. W., Marquez, C. P., Kostyrko, K., Koehne, A. L., Marini, K., Simpson, D. R., … Sweet-Cordero, E. A. (2019). Antitumor activity of an engineered decoy receptor targeting CLCF1-CNTFR signaling in lung adenocarcinoma. Nature Medicine.
- National Evaluation of Short-Term and Intermediate-Term Readmission after Esophagectomy
  Yang, C.-F. J., Wang, Y., He, H., Liou, D., Lui, N., Berry, M. F., … Backhus, L. (2019). National Evaluation of Short-Term and Intermediate-Term Readmission after Esophagectomy. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 229(4), S279–S280.
- Management of Benign Esophageal Perforation in the National Inpatient Sample
  Lui, N., Bhandari, P., Backhus, L., Liou, D., Shrager, J., & Berry, M. F. (2019). Management of Benign Esophageal Perforation in the National Inpatient Sample. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 229(4), E209.
- Broad Genomic Profiling of Bronchoalveolar Lavage Fluid in Lung Cancer
  Nair, V., Hui, A. B.-Y., Chabon, J., Esfahani, M., Stehr, H., Nabet, B., … Diehn, M. (2019). Broad Genomic Profiling of Bronchoalveolar Lavage Fluid in Lung Cancer. JOURNAL OF THORACIC ONCOLOGY, 14(10), S747–S748.
- The Oldest Old: A National Analysis of Outcomes for Patients 90 Years or Older With Lung Cancer.
  Yang, C.-F. J., Brown, A. B., Deng, J. Z., Lui, N. S., Backhus, L. M., Shrager, J. B., … Berry, M. F. (2019). The Oldest Old: A National Analysis of Outcomes for Patients 90 Years or Older With Lung Cancer. The Annals of Thoracic Surgery.
- Mapping lung cancer epithelial-mesenchymal transition states and trajectories with single-cell resolution.
  Karacosta, L. G., Anchang, B., Ignatiadis, N., Kimmey, S. C., Benson, J. A., Shrager, J. B., … Plevritis, S. K. (2019). Mapping lung cancer epithelial-mesenchymal transition states and trajectories with single-cell resolution. Nature Communications, 10(1), 5587.
- The influence of hormone replacement therapy on lung cancer incidence and mortality.
  Titan, A. L., He, H., Lui, N., Liou, D., Berry, M., Shrager, J. B., & Backhus, L. M. (2019). The influence of hormone replacement therapy on lung cancer incidence and mortality. The Journal of Thoracic and Cardiovascular Surgery.
- Transcervical Thymectomy is the Most Cost-Effective Surgical Approach in Myasthenia Gravis.
  Sholtis, C., Teymourtash, M., Berry, M., Backhus, L., Bhandari, P., He, H., … Shrager, J. (2020). Transcervical Thymectomy is the Most Cost-Effective Surgical Approach in Myasthenia Gravis. The Annals of Thoracic Surgery.
- Towards the identification of novel tumor antigens in human lung cancer.
  Chiou, S.-H., Tseng, D., Wang, C., Reuben, A., Yang, X., Wilhelmy, J., … Davis, M. (2020). Towards the identification of novel tumor antigens in human lung cancer. CANCER IMMUNOLOGY RESEARCH. AMER ASSOC CANCER RESEARCH.
- New Information on Talc and Mesothelioma.
  Shrager, J. B. (2020). New Information on Talc and Mesothelioma. The Annals of Thoracic Surgery.
- A national analysis of open versus minimally invasive thymectomy for stage I to III thymoma.
  Yang, C.-F. J., Hurd, J., Shah, S. A., Liou, D., Wang, H., Backhus, L. M., … Berry, M. F. (2019). A national analysis of open versus minimally invasive thymectomy for stage I to III thymoma. The Journal of Thoracic and Cardiovascular Surgery.
- Integrating genomic features for non-invasive early lung cancer detection.
  Chabon, J. J., Hamilton, E. G., Kurtz, D. M., Esfahani, M. S., Moding, E. J., Stehr, H., … Diehn, M. (2020). Integrating genomic features for non-invasive early lung cancer detection. Nature, 580(7802), 245–251.
- Does size matter? A national analysis of the utility of induction therapy for large thymomas.
  Liou, D. Z., Ramakrishnan, D., Lui, N. S., Shrager, J. B., Backhus, L. M., & Berry, M. F. (2020). Does size matter? A national analysis of the utility of induction therapy for large thymomas. Journal of Thoracic Disease, 12(4), 1329–41.
- Commentary: Can the esophagus curse a lung transplant?
  Shrager, J. B. (2020). Commentary: Can the esophagus curse a lung transplant? The Journal of Thoracic and Cardiovascular Surgery.
- Sub-solid lung adenocarcinoma in Asian versus Caucasian patients: different biology but similar outcomes
  Lui, N. S., Benson, J., He, H., Imielski, B. R., Kunder, C. A., Liou, D. Z., … Shrager, J. B. (2020). Sub-solid lung adenocarcinoma in Asian versus Caucasian patients: different biology but similar outcomes. JOURNAL OF THORACIC DISEASE, 12(5), 2161–71.
- A Mechanistic Clinical Trial of JaK Inhibition to Prevent Ventilator-Induced Diaphragm Dysfunction
  Shrager, J., Cooke, R., Wang, Y. J., Lee, M. S., Backhus, L., & Tang, H. B. (2020). A Mechanistic Clinical Trial of JaK Inhibition to Prevent Ventilator-Induced Diaphragm Dysfunction. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE. AMER THORACIC SOC.
- New Information on Talc and Mesothelioma
  Shrager, J. B. (2020). New Information on Talc and Mesothelioma. ANNALS OF THORACIC SURGERY, 110(3), 1099.
- A National Analysis of Treatment Patterns and Outcomes for Patients 80 Years or Older with Esophageal Cancer.
  Yang, C.-F. J., Wang, Y., Raman, V., Patel, D., Lui, N., Backhus, L., … Liou, D. (2020). A National Analysis of Treatment Patterns and Outcomes for Patients 80 Years or Older with Esophageal Cancer. Seminars in Thoracic and Cardiovascular Surgery.
- Paradoxical Motion on Sniff Test Predicts Greater Improvement Following Diaphragm Plication.
  Patel, D. C., Berry, M. F., Bhandari, P., Backhus, L. M., Raees, S., Trope, W., … Shrager, J. B. (2020). Paradoxical Motion on Sniff Test Predicts Greater Improvement Following Diaphragm Plication. The Annals of Thoracic Surgery.
- KEAP1/NFE2L2 mutations to predict local recurrence after radiotherapy but not surgery in localized non-small cell lung cancer.
  Binkley, M. S., Jeon, Y.-J., Nesselbush, M., Moding, E. J., Nabet, B., Almanza, D. S., … Diehn, M. (2020). KEAP1/NFE2L2 mutations to predict local recurrence after radiotherapy but not surgery in localized non-small cell lung cancer. JOURNAL OF CLINICAL ONCOLOGY. AMER SOC CLINICAL ONCOLOGY.
- Discovery of a novel shared tumor antigen in human lung cancer.
  Tseng, D., Chiou, S.-H., Yang, X., Reuben, A., Wilhelmy, J., McSween, A., … Davis, M. (2020). Discovery of a novel shared tumor antigen in human lung cancer. JOURNAL OF CLINICAL ONCOLOGY. AMER SOC CLINICAL ONCOLOGY.
- Cancer diagnoses and survival rise as 65-year-olds become Medicare eligible.
  Patel, D. C., He, H., Berry, M. F., Yang, C.-F. J., Trope, W., Lui, N., … Shrager, J. B. (2020). Cancer diagnoses and survival rise as 65-year-olds become Medicare eligible. JOURNAL OF CLINICAL ONCOLOGY, 38(15).
- KEAP1/NFE2L2 mutations predict lung cancer radiation resistance that can be targeted by glutaminase inhibition.
  Binkley, M. S., Jeon, Y.-J. J., Nesselbush, M., Moding, E. J., Nabet, B. Y., Almanza, D., … Diehn, M. (2020). KEAP1/NFE2L2 mutations predict lung cancer radiation resistance that can be targeted by glutaminase inhibition. Cancer Discovery.
- Early Discharge Does Not Equate to Early Return for Patients Undergoing Lobectomy for Lung Cancer: A National Analysis
  Patel, D. C., Leipzig, M., Yang, C.-F. J., Wang, Y., Shrager, J. B., Backhus, L. M., … Berry, M. F. (2020). Early Discharge Does Not Equate to Early Return for Patients Undergoing Lobectomy for Lung Cancer: A National Analysis. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS. ELSEVIER SCIENCE INC.
- A molecular cell atlas of the human lung from single-cell RNA sequencing.
  Travaglini, K. J., Nabhan, A. N., Penland, L., Sinha, R., Gillich, A., Sit, R. V., … Krasnow, M. A. (2020). A molecular cell atlas of the human lung from single-cell RNA sequencing. Nature.
- Preoperative Factors Associated with Remote Postoperative Pain Resolution and Opioid Cessation in a Mixed Surgical Cohort: Post Hoc Analysis of a Perioperative Gabapentin Trial.
  Hah, J. M., Hilmoe, H., Schmidt, P., McCue, R., Trafton, J., Clay, D., … Carroll, I. (2020). Preoperative Factors Associated with Remote Postoperative Pain Resolution and Opioid Cessation in a Mixed Surgical Cohort: Post Hoc Analysis of a Perioperative Gabapentin Trial. Journal of Pain Research, 13, 2959–70.
- Commentary: Progress, or just movement, on thymoma staging?
  Shrager, J. B. (2020). Commentary: Progress, or just movement, on thymoma staging? The Journal of Thoracic and Cardiovascular Surgery.
- Strong for Surgery: Association Between Bundled Risk Factors and Outcomes After Major Elective Surgery in the VA Population.
  Liou, D. Z., Patel, D. C., Bhandari, P., Wren, S. M., Marshall, N. J., Harris, A. H., … Backhus, L. M. (2021). Strong for Surgery: Association Between Bundled Risk Factors and Outcomes After Major Elective Surgery in the VA Population. World Journal of Surgery.
- Global analysis of shared T cell specificities in human non-small cell lung cancer enables HLA inference and antigen discovery.
  Chiou, S.-H. H., Tseng, D., Reuben, A., Mallajosyula, V., Molina, I. S., Conley, S., … Davis, M. M. (2021). Global analysis of shared T cell specificities in human non-small cell lung cancer enables HLA inference and antigen discovery. Immunity, 54(3), 586–602.e8.
- Use of a Personalized Multimedia Education Platform Improves Preoperative Teaching for Lung Cancer Patients.
  Benson, J., Bhandari, P., Lui, N., Berry, M., Liou, D. Z., Shrager, J., … Backhus, L. M. (2021). Use of a Personalized Multimedia Education Platform Improves Preoperative Teaching for Lung Cancer Patients. Seminars in Thoracic and Cardiovascular Surgery.
- Consensus for Thoracoscopic Left Upper Lobectomy-Essential Components and Targets for Simulation.
  Bryan, D. S., Ferguson, M. K., Antonoff, M. B., Backhus, L. M., Birdas, T. J., Blackmon, S. H., … Veeramachaneni, N. K. (2020). Consensus for Thoracoscopic Left Upper Lobectomy-Essential Components and Targets for Simulation. The Annals of Thoracic Surgery.
- Cancer diagnoses and survival rise as 65-year-olds become Medicare-eligible.
  Patel, D. C., He, H., Berry, M. F., Yang, C.-F. J., Trope, W. L., Wang, Y., … Shrager, J. B. (2021). Cancer diagnoses and survival rise as 65-year-olds become Medicare-eligible. Cancer.
- Randomized Phase II Study of 3 Months or 2 Years of Adjuvant Afatinib in Patients With Surgically Resected Stage I-III EGFR-Mutant Non-Small-Cell Lung Cancer
  Neal, J. W., Costa, D. B., Muzikansky, A., Shrager, J. B., Lanuti, M., Huang, J., … Chaft, J. E. (2021). Randomized Phase II Study of 3 Months or 2 Years of Adjuvant Afatinib in Patients With Surgically Resected Stage I-III EGFR-Mutant Non-Small-Cell Lung Cancer. JCO PRECISION ONCOLOGY, 5, 325–32.
- Impact of the Surgical Approach to Thymectomy Upon Complete Stable Remission Rates in Myasthenia Gravis: A Meta-analysis.
  Solis-Pazmino, P., Baiu, I., Lincango-Naranjo, E., Trope, W., Prokop, L., Ponce, O. J., & Shrager, J. B. (2021). Impact of the Surgical Approach to Thymectomy Upon Complete Stable Remission Rates in Myasthenia Gravis: A Meta-analysis. Neurology.
- Investigating gene expression profiles associated with clinical radiation resistance in KEAP1/NFE2L2 wildtype lung cancer.
  Binkley, M. S., Jeon, Y.-J., Nesselbush, M., Moding, E. J., Nabet, B., Almanza, D., … Diehn, M. (2021). Investigating gene expression profiles associated with clinical radiation resistance in KEAP1/NFE2L2 wildtype lung cancer. CLINICAL CANCER RESEARCH. AMER ASSOC CANCER RESEARCH.
- Early Discharge after Lobectomy for Lung Cancer does not Equate to Early Readmission.
  Patel, D. C., Leipzig, M., Jeffrey Yang, C.-F., Wang, Y., Shrager, J. B., Backhus, L. M., … Berry, M. F. (2021). Early Discharge after Lobectomy for Lung Cancer does not Equate to Early Readmission. The Annals of Thoracic Surgery.
- Influence of facility volume on long-term survival of patients undergoing esophagectomy for esophageal cancer.
  Patel, D. C., Jeffrey Yang, C.-F., He, H., Liou, D. Z., Backhus, L. M., Lui, N. S., … Berry, M. F. (2021). Influence of facility volume on long-term survival of patients undergoing esophagectomy for esophageal cancer. The Journal of Thoracic and Cardiovascular Surgery.
- Short-term and intermediate-term readmission after esophagectomy
  Wang, Y., Yang, C.-F. J., He, H., Buchan, J. M., Patel, D. C., Liou, D. Z., … Backhus, L. M. (2021). Short-term and intermediate-term readmission after esophagectomy. JOURNAL OF THORACIC DISEASE.
- Induction therapy is not associated with improved survival in large cT4N0 non-small cell lung cancers.
  Sun, B. J., Bhandari, P., Jeffrey Yang, C.-F., Berry, M. F., Shrager, J. B., Backhus, L. M., … Liou, D. Z. (2021). Induction therapy is not associated with improved survival in large cT4N0 non-small cell lung cancers. The Annals of Thoracic Surgery.
- Surgical resection for patients with pulmonary aspergillosis in the national inpatient sample.
  Patel, D. C., Bhandari, P., Epstein, D. J., Liou, D. Z., Backhus, L. M., Berry, M. F., … Lui, N. S. (2021). Surgical resection for patients with pulmonary aspergillosis in the national inpatient sample. Journal of Thoracic Disease, 13(8), 4977–4987.
- Short-term and intermediate-term readmission after esophagectomy.
  Wang, Y., Yang, C.-F. J., He, H., Buchan, J. M., Patel, D. C., Liou, D. Z., … Backhus, L. M. (2021). Short-term and intermediate-term readmission after esophagectomy. Journal of Thoracic Disease, 13(8), 4678–4689.
- Rationale and design of a mechanistic clinical trial of JAK inhibition to prevent ventilator-induced diaphragm dysfunction.
  Shrager, J. B., Wang, Y., Lee, M., Nesbit, S., Trope, W., Konsker, H., … Tang, H. (2021). Rationale and design of a mechanistic clinical trial of JAK inhibition to prevent ventilator-induced diaphragm dysfunction. Respiratory Medicine, 189, 106620.
- Consensus for Thoracoscopic Lower Lobectomy: Essential Components and Targets for Simulation.
  Erwin, P. A., Lee, A. C., Ahmad, U., Antonoff, M., Arndt, A., Backhus, L., … Ferguson, M. K. (2021). Consensus for Thoracoscopic Lower Lobectomy: Essential Components and Targets for Simulation. The Annals of Thoracic Surgery.
- Perioperative Outcomes After Combined Esophagectomy and Lung Resection.
  Patel, D. C., Bhandari, P., Shrager, J. B., Berry, M. F., Backhus, L. M., Lui, N. S., & Liou, D. Z. (2021). Perioperative Outcomes After Combined Esophagectomy and Lung Resection. The Journal of Surgical Research, 270, 413–420.
- A new model using artificial intelligence to predict recurrence after surgical resection of stage I-II non-small cell lung cancer.
  Lui, N., Wei, N., Trope, W., Nesbit, S., Bhandari, P., Lee, C.-H., … Yang, E. (2021). A new model using artificial intelligence to predict recurrence after surgical resection of stage I-II non-small cell lung cancer. JOURNAL OF CLINICAL ONCOLOGY. LIPPINCOTT WILLIAMS & WILKINS.
- Multi-omics analysis of spatially distinct stromal cells reveals tumor-induced O-glycosylation of the CDK4-pRB axis in fibroblasts at the invasive tumor edge.
  Bouchard, G., Garcia-Marques, F. J., Karacosta, L. G., Zhang, W., Bermudez, A., Riley, N. M., … Plevritis, S. K. (2021). Multi-omics analysis of spatially distinct stromal cells reveals tumor-induced O-glycosylation of the CDK4-pRB axis in fibroblasts at the invasive tumor edge. Cancer Research.
- The role of induction therapy for thymic malignancies: a narrative review.
  Patel, D. C., Shrager, J. B., & Padda, S. K. (2020). The role of induction therapy for thymic malignancies: a narrative review. Mediastinum (Hong Kong, China), 4, 36.
- Textbook outcome after minimally invasive esophagectomy is an important prognostic indicator for predicting long-term oncological outcomes with locally advanced esophageal squamous cell carcinoma.
  Xu, S.-J. J., Lin, L.-Q. Q., Chen, C., Chen, T.-Y. Y., You, C.-X. X., Chen, R.-Q. Q., … Chen, S.-C. C. (2022). Textbook outcome after minimally invasive esophagectomy is an important prognostic indicator for predicting long-term oncological outcomes with locally advanced esophageal squamous cell carcinoma. Annals of Translational Medicine, 10(4), 161.
- Reconstructing codependent cellular cross-talk in lung adenocarcinoma using REMI.
  Yu, A., Li, Y., Li, I., Ozawa, M. G., Yeh, C., Chiou, A. E., … Plevritis, S. K. (2022). Reconstructing codependent cellular cross-talk in lung adenocarcinoma using REMI. Science Advances, 8(11), eabi4757.
- Silver Nitrate-Coated Versus Standard Indwelling Pleural Catheter for Malignant Effusions: The SWIFT Randomized Trial.
  Shrager, J. B., Bhatnagar, R., Kearney, C. T., Retzlaff, N. P., Cohen, E., Stanton, A. E., … Maskell, N. A. (2022). Silver Nitrate-Coated Versus Standard Indwelling Pleural Catheter for Malignant Effusions: The SWIFT Randomized Trial. Annals of the American Thoracic Society.
- Effect of Perioperative Gabapentin on Postoperative Pain Resolution and Opioid Cessation in a Mixed Surgical Cohort: A Randomized Clinical Trial (vol 153, pg 303, 2018)
  Hah, J., Mackey, S. C., & Schmidt, P. (2022). Effect of Perioperative Gabapentin on Postoperative Pain Resolution and Opioid Cessation in a Mixed Surgical Cohort: A Randomized Clinical Trial (vol 153, pg 303, 2018). JAMA SURGERY.
- Positron emission tomography/computed tomography differentiates resectable thymoma from anterior mediastinal lymphoma.
  Byrd, C. T., Trope, W. L., Bhandari, P., Konsker, H. B., Moradi, F., Lui, N. S., … Shrager, J. B. (2022). Positron emission tomography/computed tomography differentiates resectable thymoma from anterior mediastinal lymphoma. The Journal of Thoracic and Cardiovascular Surgery.
- Half of Anastomotic Leaks after Esophagectomy are Undetected on Initial Postoperative Esophagram.
  Elliott, I. A., Berry, M. F., Trope, W., Lui, N. S., Guenthart, B. A., Liou, D. Z., … Shrager, J. B. (2022). Half of Anastomotic Leaks after Esophagectomy are Undetected on Initial Postoperative Esophagram. The Annals of Thoracic Surgery.
- Genomic Profiling of Bronchoalveolar Lavage Fluid in Lung Cancer.
  Nair, V. S., Hui, A. B., Chabon, J. J., Shahrokh Esfahani, M., Stehr, H., Nabet, B. Y., … Diehn, M. (2022). Genomic Profiling of Bronchoalveolar Lavage Fluid in Lung Cancer. Cancer Research.
- Lobar versus sublobar resection in clinical stage IA primary lung cancer with occult N2 disease.
  Liou, D. Z., Chan, M., Bhandari, P., Lui, N. S., Backhus, L. M., Shrager, J. B., & Berry, M. F. (2022). Lobar versus sublobar resection in clinical stage IA primary lung cancer with occult N2 disease. European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery.
- Eligibility for Lung Cancer Screening Among Women Receiving Screening for Breast Cancer.
  Titan, A. L., Baiu, I., Liou, D., Lui, N. S., Berry, M., Shrager, J., & Backhus, L. (2022). Eligibility for Lung Cancer Screening Among Women Receiving Screening for Breast Cancer. JAMA Network Open, 5(9), e2233840.
- Risk of adenocarcinoma in patients with a suspicious ground-glass opacity: a retrospective review
  Roy, E., Shrager, J., Benson, J., Trope, W. L., Bhandari, P., Lui, N., … Berry, M. F. (2022). Risk of adenocarcinoma in patients with a suspicious ground-glass opacity: a retrospective review. JOURNAL OF THORACIC DISEASE.
- Phenotyping Malignant Pleural Effusions with Mass Cytometry: Evidence of EMT and MET States in Late-Stage NSCLC
  Karacosta, L. G., Pancirer, D., Preiss, J., Shrager, J. B., Sung, A. W., Neal, J. W., … Plevritis, S. K. (2022). Phenotyping Malignant Pleural Effusions with Mass Cytometry: Evidence of EMT and MET States in Late-Stage NSCLC. JOURNAL OF THORACIC ONCOLOGY. ELSEVIER SCIENCE INC.
- Impact of Delaying Surgery After Chemoradiation on Outcomes for Locally Advanced Esophageal Squamous Cell Carcinoma.
  Wong, L.-Y., Liou, D. Z., Vitzthum, L. K., Backhus, L. M., Lui, N. S., Chang, D., … Berry, M. F. (2022). Impact of Delaying Surgery After Chemoradiation on Outcomes for Locally Advanced Esophageal Squamous Cell Carcinoma. Annals of Surgical Oncology.
- ASO Visual Abstract: Impact of Delaying Surgery After Chemoradiation on Outcomes for Locally Advanced Esophageal Squamous Cell Carcinoma.
  Wong, L.-Y. Y., Liou, D. Z., Vitzthum, L. K., Backhus, L. M., Lui, N. S., Chang, D., … Berry, M. F. (2023). ASO Visual Abstract: Impact of Delaying Surgery After Chemoradiation on Outcomes for Locally Advanced Esophageal Squamous Cell Carcinoma. Annals of Surgical Oncology.
- Surgical Management of Esophageal Perforation: Examining Trends in a Multi-Institutional Cohort.
  Wong, L.-Y. Y., Leipzig, M., Liou, D. Z., Backhus, L. M., Lui, N. S., Shrager, J. B., & Berry, M. F. (2023). Surgical Management of Esophageal Perforation: Examining Trends in a Multi-Institutional Cohort. Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract.
- Characterization of Epidural Analgesia Interruption and Associated Outcomes After Esophagectomy.
  Byrd, C. T., Kim, R. K., Manapat, P., He, H., Tsui, B. C., Shrager, J. B., … Liou, D. Z. (2023). Characterization of Epidural Analgesia Interruption and Associated Outcomes After Esophagectomy. The Journal of Surgical Research, 290, 92–100.
- The impact of neoadjuvant immunotherapy on perioperative outcomes and survival after esophagectomy for esophageal cancer.
  Wong, L.-Y., Liou, D. Z., Backhus, L. M., Lui, N. S., Shrager, J. B., & Berry, M. F. (2023). The impact of neoadjuvant immunotherapy on perioperative outcomes and survival after esophagectomy for esophageal cancer. JTCVS Open, 14, 547–560.
- p53 governs an AT1 differentiation programme in lung cancer suppression.
  Kaiser, A. M., Gatto, A., Hanson, K. J., Zhao, R. L., Raj, N., Ozawa, M. G., … Attardi, L. D. (2023). p53 governs an AT1 differentiation programme in lung cancer suppression. Nature.
- KRAS(G12D) drives lepidic adenocarcinoma through stem-cell reprogramming.
  Juul, N. H., Yoon, J.-K. K., Martinez, M. C., Rishi, N., Kazadaeva, Y. I., Morri, M., … Desai, T. J. (2023). KRAS(G12D) drives lepidic adenocarcinoma through stem-cell reprogramming. Nature.
- Does delaying surgery following induction chemotherapy compromise survival in patients with mesothelioma?
  Wong, L.-Y., Baiu, I., Leipzig, M., Titan, A., Liou, D. Z., Lui, N., … Backhus, L. (2023). Does delaying surgery following induction chemotherapy compromise survival in patients with mesothelioma? JOURNAL OF CANCER METASTASIS AND TREATMENT, 9.
- We should be considering lung cancer screening for never-smoking Asian-American females.
  Kamtam, D. N., & Shrager, J. B. (2023). We should be considering lung cancer screening for never-smoking Asian-American females. The Journal of Thoracic and Cardiovascular Surgery.
- The colocatome as a spatial -omic reveals shared microenvironment features between tumour-stroma assembloids and human lung cancer.
  Bouchard, G., Zhang, W., Li, I., Ilerten, I., Bhattacharya, A., Li, Y., … Plevritis, S. K. (2023). The colocatome as a spatial -omic reveals shared microenvironment features between tumour-stroma assembloids and human lung cancer. BioRxiv : the Preprint Server for Biology.
- Organoid modeling of lung-resident immune responses to SARS-CoV-2 infection.
  Choi, S. S., van Unen, V., Zhang, H., Rustagi, A., Alwahabi, S. A., Santos, A. J., … Kuo, C. J. (2023). Organoid modeling of lung-resident immune responses to SARS-CoV-2 infection. Research Square.
- Impact of hyperthermic intrathoracic chemotherapy (HITHOC) during resection of pleural mesothelioma on patient survival
  Elliott, I. A., He, H., Lui, N. S., Liou, D. Z., Guenthart, B. A., Shrager, J. B., … Backhus, L. M. (2023). Impact of hyperthermic intrathoracic chemotherapy (HITHOC) during resection of pleural mesothelioma on patient survival. JOURNAL OF THORACIC DISEASE.
- Outcomes of a Failed Observation Approach for Paraesophageal Hernia
  Wong, L.-yeng, Leipzig, M., Elliott, I. A., Lui, N., Liou, D., Backhus, L. M., … Berry, M. (2023). Outcomes of a Failed Observation Approach for Paraesophageal Hernia. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS. LIPPINCOTT WILLIAMS & WILKINS.
- Phenotyping EMT and MET cellular states in lung cancer patient liquid biopsies at a personalized level using mass cytometry.
  Karacosta, L. G., Pancirer, D., Preiss, J. S., Benson, J. A., Trope, W., Shrager, J. B., … Plevritis, S. K. (2023). Phenotyping EMT and MET cellular states in lung cancer patient liquid biopsies at a personalized level using mass cytometry. Scientific Reports, 13(1), 21781.
- Outcomes of a Failed Observation Approach for Paraesophageal Hernia
  Wong, L.-yeng, Leipzig, M., Elliott, I. A., Lui, N., Liou, D., Backhus, L. M., … Berry, M. (2023). Outcomes of a Failed Observation Approach for Paraesophageal Hernia. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS. LIPPINCOTT WILLIAMS & WILKINS.
- Impact of hyperthermic intrathoracic chemotherapy (HITHOC) during resection of pleural mesothelioma on patient survival.
  Elliott, I. A., He, H., Lui, N. S., Liou, D. Z., Guenthart, B. A., Shrager, J. B., … Backhus, L. M. (2023). Impact of hyperthermic intrathoracic chemotherapy (HITHOC) during resection of pleural mesothelioma on patient survival. Journal of Thoracic Disease, 15(11), 6140–6150.
- Risk of developing subsequent primary lung cancer after receiving radiation for breast cancer.
  Wong, L.-Y., Kapula, N., He, H., Guenthart, B. A., Vitzthum, L. K., Horst, K., … Elliott, I. A. (2023). Risk of developing subsequent primary lung cancer after receiving radiation for breast cancer. JTCVS Open, 16, 919–928.
- The impact of refusing esophagectomy for treatment of locally advanced esophageal adenocarcinoma.
  Wong, L.-Y., Elliott, I. A., Liou, D. Z., Backhus, L. M., Lui, N. S., Shrager, J. B., & Berry, M. F. (2023). The impact of refusing esophagectomy for treatment of locally advanced esophageal adenocarcinoma. JTCVS Open, 16, 987–995.
- Comparison of failure to rescue in younger versus elderly patients following lung cancer resection.
  Wang, Y., Kapula, N., Yang, C.-F. J., Manapat, P., Elliott, I. A., Guenthart, B. A., … Liou, D. Z. (2023). Comparison of failure to rescue in younger versus elderly patients following lung cancer resection. JTCVS Open, 16, 855–872.
- Impact of guideline therapy on survival of patients with stage I-III epithelioid mesothelioma.
  Liou, D. Z., Wang, Y., Bhandari, P., Shrager, J. B., Lui, N. S., Backhus, L. M., & Berry, M. F. (2023). Impact of guideline therapy on survival of patients with stage I-III epithelioid mesothelioma. Journal of Thoracic Disease, 15(12), 6661–6673.
- Clinical Impact of EGFR vs KRAS Mutations in Multifocal Lung Adenocarcinoma
  Jiang, J., Berry, M. F., Lui, N. S., Liou, D. Z., Trope, W. L., Backhus, L. M., & Shrager, J. B. (2023). Clinical Impact of EGFR vs KRAS Mutations in Multifocal Lung Adenocarcinoma. JOURNAL OF THORACIC ONCOLOGY. ELSEVIER SCIENCE INC.
- Outcomes of surgery for catastrophic hiatal hernia presentations.
  Wong, L.-Y., Leipzig, M., Elliott, I. A., Liou, D. Z., Backhus, L. M., Shrager, J. B., & Berry, M. F. (2024). Outcomes of surgery for catastrophic hiatal hernia presentations. Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract, 28(3), 285–286.
- Lepidic-Type Lung Adenocarcinomas: Is It Safe to Observe for Growth Prior to Treating?
  Wong, L.-Y. Y., Elliott, I. A., Liou, D. Z., Backhus, L. M., Lui, N. S., Shrager, J. B., & Berry, M. F. (2024). Lepidic-Type Lung Adenocarcinomas: Is It Safe to Observe for Growth Prior to Treating? The Annals of Thoracic Surgery.
- The Impact of Immunotherapy Use in Stage IIIA (T1-2N2) NSCLC: A Nationwide Analysis.
  Wong, L.-Y. Y., Liou, D. Z., Roy, M., Elliott, I. A., Backhus, L. M., Lui, N. S., … Berry, M. F. (2024). The Impact of Immunotherapy Use in Stage IIIA (T1-2N2) NSCLC: A Nationwide Analysis. JTO Clinical and Research Reports, 5(3), 100654.
- Complications of Outpatient Chest Tube Management for Prolonged Air Leaks After Pulmonary Surgery.
  Randle, R. J., Bhandari, P., He, H., Berry, M. F., Backhus, L. M., Lui, N. S., … Shrager, J. B. (2024). Complications of Outpatient Chest Tube Management for Prolonged Air Leaks After Pulmonary Surgery. Annals of Surgical Oncology.
- Interstitial macrophages are a focus of viral takeover and inflammation in COVID-19 initiation in human lung.
  Wu, T. T.-H., Travaglini, K. J., Rustagi, A., Xu, D., Zhang, Y., Andronov, L., … Krasnow, M. A. (2024). Interstitial macrophages are a focus of viral takeover and inflammation in COVID-19 initiation in human lung. The Journal of Experimental Medicine, 221(6).
- First in human Phase I Clinical Trial of Stereotactic Irradiation to Achieve Lung Volume Reduction (SILVR) in Severe Emphysema.
  Kamtam, D. N., Binkley, M. S., Kapula, N., Sadeghi, C., Nesbit, S., Md, H. H., … Shrager, J. B. (2024). First in human Phase I Clinical Trial of Stereotactic Irradiation to Achieve Lung Volume Reduction (SILVR) in Severe Emphysema. International Journal of Radiation Oncology, Biology, Physics.
- Randomized controlled trials in lung cancer surgery: How are we doing?
  Wong, L.-Y. Y., Li, Y., Elliott, I. A., Backhus, L. M., Berry, M. F., Shrager, J. B., & Oh, D. S. (2024). Randomized controlled trials in lung cancer surgery: How are we doing? JTCVS Open, 18, 234–252.
- What is an Adequate Margin During Sublobar Resection of =3cm N0 Subsolid Lung Adenocarcinomas?
  Kamtam, D. N., Berry, M. F., Lui, N. S., Satoyoshi, M., Elliott, I. A., Liou, D. Z., … Shrager, J. B. (2024). What is an Adequate Margin During Sublobar Resection of =3cm N0 Subsolid Lung Adenocarcinomas? The Annals of Thoracic Surgery.
- Barriers to Completing Low Dose Computed Tomography Scan for Lung Cancer Screening.
  Wong, L.-Y. Y., Choudhary, S., Kapula, N., Lin, M., Elliott, I. A., Guenthart, B. A., … Lui, N. S. (2024). Barriers to Completing Low Dose Computed Tomography Scan for Lung Cancer Screening. Clinical Lung Cancer.
- ASO Visual Abstract: Complications of Outpatient Chest Tube Management for Prolonged Air Leaks After Pulmonary Surgery.
  Randle, R. J., Bhandari, P., He, H., Berry, M. F., Backhus, L. M., Lui, N. S., … Shrager, J. B. (2024). ASO Visual Abstract: Complications of Outpatient Chest Tube Management for Prolonged Air Leaks After Pulmonary Surgery. Annals of Surgical Oncology.
- Impacts of Positive Margins and Surgical Extent on Outcomes after Early-Stage Lung Cancer Resection.
  Wong, L.-Y. Y., Dale, R., Kapula, N., Elliott, I. A., Liou, D. Z., Backhus, L. M., … Berry, M. F. (2024). Impacts of Positive Margins and Surgical Extent on Outcomes after Early-Stage Lung Cancer Resection. The Annals of Thoracic Surgery.
- The 2023 American Association for Thoracic Surgery (AATS) Expert Consensus Document: Management of subsolid lung nodules.
  Chen, H., Kim, A. W., Hsin, M., Shrager, J. B., Prosper, A. E., Wahidi, M. M., … Yanagawa, J. (2024). The 2023 American Association for Thoracic Surgery (AATS) Expert Consensus Document: Management of subsolid lung nodules. The Journal of Thoracic and Cardiovascular Surgery.
- Clinical impact of EGFR and KRAS mutations in surgically treated unifocal and multifocal lung adenocarcinoma.
  Jiang, J., Berry, M. F., Lui, N. S., Liou, D. Z., Trope, W. L., Backhus, L. M., & Shrager, J. B. (2024). Clinical impact of EGFR and KRAS mutations in surgically treated unifocal and multifocal lung adenocarcinoma. Translational Lung Cancer Research, 13(6), 1222–1231.
- JAK inhibition with tofacitinib rapidly increases contractile force in human skeletal muscle.
  Shrager, J. B., Randle, R., Lee, M., Ahmed, S. S., Trope, W., Lui, N., … Tang, H. (2024). JAK inhibition with tofacitinib rapidly increases contractile force in human skeletal muscle. Life Science Alliance, 7(11).
- Greater ipsilateral rectus muscle atrophy after robotic thoracic surgery compared with open and video-assisted thoracoscopic surgery approaches.
  Wang, Y., Randle, R. J., Bhandari, P., He, H., Trope, W. L., Guenthart, B. A., … Lui, N. S. (2024). Greater ipsilateral rectus muscle atrophy after robotic thoracic surgery compared with open and video-assisted thoracoscopic surgery approaches. JTCVS Open, 20, 202–209.
- Initial Patient Characteristics of TSOG 102: A Multicenter Prospective Registry of Active Surveillance in Patients with Multiple Ground Glass Opacities.
  Huang, J., Tan, K. S., Altorki, N., Antonoff, M., Blackmon, S., Bueno, R., … Jones, D. R. (2024). Initial Patient Characteristics of TSOG 102: A Multicenter Prospective Registry of Active Surveillance in Patients with Multiple Ground Glass Opacities. The Journal of Thoracic and Cardiovascular Surgery.
- The Society of Thoracic Surgeons Expert Consensus on the Multidisciplinary Management and Resectability of Locally Advanced Non-Small Cell Lung Cancer.
  Kim, S. S., Cooke, D. T., Kidane, B., Tapias, L. F., Lazar, J. F., Awori Hayanga, J. W., … Shrager, J. B. (2024). The Society of Thoracic Surgeons Expert Consensus on the Multidisciplinary Management and Resectability of Locally Advanced Non-Small Cell Lung Cancer. The Annals of Thoracic Surgery.
- The Role of Primary Care Providers in Lung Cancer Screening: A Cross-Sectional Survey.
  Wong, L.-Y. Y., Kapula, N., Kang, A., Phadke, A. J., Schechtman, A. D., Elliott, I. A., … Lui, N. S. (2024). The Role of Primary Care Providers in Lung Cancer Screening: A Cross-Sectional Survey. Clinical Lung Cancer.
- Segmentectomy vs Lobectomy for Non-Small Cell Lung Cancer: The Impact of Tumor Location.
  Wong, L.-Y. Y., Kapula, N., Elliott, I. A., Liou, D. Z., Backhus, L. M., Lui, N. S., … Berry, M. F. (2024). Segmentectomy vs Lobectomy for Non-Small Cell Lung Cancer: The Impact of Tumor Location. Annals of Thoracic Surgery Short Reports, 2(3), 458–463.
- The Impact of Tumor Size on Node Involvement in Typical Lung Carcinoids.
  Elliott, I. A., Liou, D. Z., Lui, N. S., Backhus, L. M., Shrager, J. B., Myall, N., & Berry, M. F. (2023). The Impact of Tumor Size on Node Involvement in Typical Lung Carcinoids. Annals of Thoracic Surgery Short Reports, 1(4), 543–547.
- The association of chylothorax with aggressiveness of lymph node management during pulmonary resection.
  Kamtam, D. N., Berry, M. F., Lin, N., Kapula, N., Kim, J. J., Wallen, B., … Shrager, J. B. (2025). The association of chylothorax with aggressiveness of lymph node management during pulmonary resection. The Annals of Thoracic Surgery.
- A quantitative spatial cell-cell colocalizations framework enabling comparisons between in vitro assembloids and pathological specimens.
  Bouchard, G., Zhang, W., Ilerten, I., Li, I., Bhattacharya, A., Li, Y., … Plevritis, S. K. (2025). A quantitative spatial cell-cell colocalizations framework enabling comparisons between in vitro assembloids and pathological specimens. Nature Communications, 16(1), 1392.
- Radiation therapy does not improve survival in patients who are upstaged after esophagectomy for clinical early-stage esophageal adenocarcinoma
  Kamtam, D. N., Lin, N., Liou, D. Z., Lui, N. S., Backhus, L. M., Shrager, J. B., & Berry, M. F. (2025). Radiation therapy does not improve survival in patients who are upstaged after esophagectomy for clinical early-stage esophageal adenocarcinoma. JTCVS OPEN, 23, 290–308.
- Novel Robotic Esophagogastric Anastomosis Simulation Model for Skill Development and Training.
  Wong, L.-Y., Kamtam, D., Kim, J., Wallen, B., Elliott, I. A., Guenthart, B. A., … Lui, N. S. (2025). Novel Robotic Esophagogastric Anastomosis Simulation Model for Skill Development and Training. Annals of Thoracic Surgery Short Reports, 3(1), 206–211.
- Utility of PET for Nodal Staging in Subsolid Clinical Stage IA (T1 N0) Lung Adenocarcinoma.
  Kamtam, D. N., Shrager, J. B., Elliott, I. A., Guo, H. H., Guenthart, B. A., Liou, D. Z., … Berry, M. F. (2025). Utility of PET for Nodal Staging in Subsolid Clinical Stage IA (T1 N0) Lung Adenocarcinoma. Annals of Thoracic Surgery Short Reports, 3(1), 118–122.
- Three-Dimensional Printed Model of the Mediastinum for Cardiothoracic Surgery Resident Education.
  Byrd, C. T., Trope, W. L., Guo, H. H., Gifford, K., Bhandari, P., Benson, J., … Lui, N. S. (2025). Three-Dimensional Printed Model of the Mediastinum for Cardiothoracic Surgery Resident Education. Annals of Thoracic Surgery Short Reports, 3(1), 193–199.
- Community Awareness of Lung Cancer Screening: A Cross-Sectional Survey.
  Ryan, L. C., Choudhary, S., Kapula, N., Kang, A., Shula, L. G., Elliott, I. A., … Lui, N. S. (2025). Community Awareness of Lung Cancer Screening: A Cross-Sectional Survey. Annals of Thoracic Surgery Short Reports, 3(1), 113–117.
- Overexpression of thioredoxin-2 attenuates age-related muscle loss by suppressing mitochondrial oxidative stress and apoptosis.
  Tang, H., Kim, M., Lee, M., Baumann, K., Olguin, F., He, H., … Shrager, J. B. (2022). Overexpression of thioredoxin-2 attenuates age-related muscle loss by suppressing mitochondrial oxidative stress and apoptosis. JCSM Rapid Communications, 5(1), 130–145.

View More Publications

Clinical Trials

Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.

Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.

Open Trials Closed Trials

Janus Kinase Inhibition to Prevent Ventilator-induced Diaphragm Dysfunction

GSK1572932A Antigen-Specific Cancer Immunotherapeutic as Adjuvant Therapy in Patients With Non-Small Cell Lung Cancer

Randomized Study to Compare CyberKnife to Surgical Resection In Stage I Non-small Cell Lung Cancer

Safety and Effectiveness of a New Pleural Catheter for Symptomatic, Recurrent, MPEs Versus Approved Pleural Catheter

Surgery With or Without Internal Radiation Therapy Compared With Stereotactic Body Radiation Therapy in Treating Patients With High-Risk Stage I Non-Small Cell Lung Cancer

Specializing In

Myasthenia Gravis
Non-Tuberculosis Mycobacterial Infections
Paraesophageal Hernias
Pleural Diseases
Soft Tissue Sarcoma

Practice Locations

Thoracic Surgery Clinic in Palo Alto Palo Alto, CA

Palo Alto, CA

Thoracic Surgery Clinic in Palo Alto

875 Blake Wilbur Dr

Palo Alto , CA 94304

(650) 498-6000

More Clinic Information

Thoracic Cancer Program in Palo Alto Palo Alto, CA

Palo Alto, CA

Thoracic Cancer Program in Palo Alto

875 Blake Wilbur Dr

Palo Alto , CA 94304

(650) 498-6000

More Clinic Information

Esophagus Center Redwood City, CA

Redwood City, CA

Esophagus Center

420 Broadway, Pavilion D Fl 2

Redwood City , CA 94063

(650) 736-5555

More Clinic Information

Chest Wall Surgery Program Palo Alto, CA

Palo Alto, CA

Chest Wall Surgery Program

875 Blake Wilbur Dr

Palo Alto , CA 94304

(650) 498-6000

More Clinic Information

Important Information about Our Organizations and Physician Affiliation

Stanford Health Care, Stanford Health Care Tri-Valley, and Stanford Medicine Partners are each independent nonprofit organizations that are affiliated with but separate from each other and from Stanford University. The physicians who provide care at facilities operated by Stanford Health Care, Stanford Health Care Tri-Valley, and Stanford Medicine Partners are faculty, foundation, or community physicians who are not employees, representatives, or agents of Stanford Health Care, Stanford Health Care Tri- Valley, or Stanford Medicine Partners. Stanford Health Care, Stanford Health Care Tri-Valley, and Stanford Medicine Partners do not exercise control over the care provided by such faculty, foundation, and community physicians and are not responsible for their actions.

Patient Ratings

(22 Ratings)

Overall Rating

4.9/5

View Ratings by Category

5.0/5

Friendliness

4.9/5

Explanations

4.9/5

Listens

5.0/5

Care provider's efforts to include you in decisions about your care

4.9/5

Recommended to others

0.0/5

Wait times

How Our Ratings Work

The Patients Ratings and comments are gathered from our Patient Satisfaction Survey and displayed in their entirety.

Patient Satisfaction Survey Disclaimer

Patient Reviews

(202 reviews)

My surgeon - somewhat of a godly person to me!

Jan 2025

•

Verified SHC Patient

muchas gracias por su tiempo

Dec 2024

•

Verified SHC Patient

Dr. Shrager did an excellent job at successfully performing a lobectomy which removed a cancerous tumor from my lungs without any remission. Thank you.

Nov 2024

•

Verified SHC Patient

Best Dr. and assistants

Nov 2024

•

Verified SHC Patient

He gave me confidence in his knowledge and ability to take care of the upcoming surgery and follow up care. Very professional.

Nov 2024

•

Verified SHC Patient

good job

Oct 2024

•

Verified SHC Patient

Dr. Shrager was very kind and helpful. I appreciate how straightforward the whole appointment was and I know exactly what to expect from him.

Oct 2024

•

Verified SHC Patient

Dr. Sprayers qualifications are great, I feel Iâ€™m in good hands.

Oct 2024

•

Verified SHC Patient

A very Good doctor, who cares about the patients.

Oct 2024

•

Verified SHC Patient

Knows what he is doing. No issues with him.

Sep 2024

•

Verified SHC Patient

He is very thoughtful, thorough and kind. He is also very knowledgeable and forthright.

Aug 2024

•

Verified SHC Patient

I value his opinion in the highest regard.

Aug 2024

•

Verified SHC Patient

He is very knowledgeable and straightforward. He was very willing to listen to my concerns and questions, and was very responsive.

Jul 2024

•

Verified SHC Patient

He is kind and professional and dedicated.

Jul 2024

•

Verified SHC Patient

Very informative. We appreciate his clear communication about steps moving forward. Thank you, Dr. Shrager!

Jul 2024

•

Verified SHC Patient

He is a very nice and experienced doctor.

Jul 2024

•

Verified SHC Patient

The doctor is excellent

Jun 2024

•

Verified SHC Patient

Very thorough and kind

Jun 2024

•

Verified SHC Patient

Confident without any arrogance. Of course, he is also extremely capable. High recommendation!

Jun 2024

•

Verified SHC Patient

Dr Shrager is very knowledgeable, I would recommend him to anyone. He was also my sister's lung doctor.

Jun 2024

•

Verified SHC Patient

he his good

Apr 2024

•

Verified SHC Patient

I thought Dr. Shrager was thoughtful and very thorough. I appreciate his to-the-point approach, and I feel like I am in good hands.

Apr 2024

•

Verified SHC Patient

excellent treatment and excellent results

Feb 2024

•

Verified SHC Patient

We feel a great connection with Dr. Shrager and are happy he is taking care of my cancer issues.

Feb 2024

•

Verified SHC Patient

Dr. Joseph Shrager was very patient and answered all my questions. Heâ€™s very knowledgeable and professional. ðŸ™ ðŸŒ·ðŸŒ·

Jan 2024

•

Verified SHC Patient

Dr. Joseph Shrager is an excellent surgeon/doctor and the best there is. I feel at ease under his care. Thank you!

Jan 2024

•

Verified SHC Patient

Dr. Joseph Shrager is concerned about what happened to me when I was hospitalized and did immediate plan to check my condition. I apprecate it very much the concerned he giving to his patient like me.

Jan 2024

•

Verified SHC Patient

Before he talked to me he was well aware of the nature and history of my case

Jan 2024

•

Verified SHC Patient

Excellent surgeon, clear articulation of procedure.

Jan 2024

•

Verified SHC Patient

He is very knowledgeable and informative

Jan 2024

•

Verified SHC Patient

Very pleasant . Answers questions.

Dec 2023

•

Verified SHC Patient

10/10

Nov 2023

•

Verified SHC Patient

Dr. Shrager, covered all my questions quite well, he is precise, efficient and very knowledgeable.

Nov 2023

•

Verified SHC Patient

Wonderful Doctor.

Nov 2023

•

Verified SHC Patient

Very knowledgeable. Already had a game plan in mind before the meeting started. Straight to the point.

Nov 2023

•

Verified SHC Patient

Iâ€™m extremely grateful that Dr. Shrager was my surgeon. His follow up is excellent.

Nov 2023

•

Verified SHC Patient

He was great answered all questions and set up the next steps.

Nov 2023

•

Verified SHC Patient

muy bueno

Oct 2023

•

Verified SHC Patient

Dr. Shrager makes me feel he cares about my health. He followed up after my surgery on a suspicious CT scan for more nodules. I really appreciate his dedication to his patients. Thank you Dr. Shrager

Sep 2023

•

Verified SHC Patient

He is very clear and understanding. He explains very well what my options are and our next steps should be.

Sep 2023

•

Verified SHC Patient

He is caring and so knowledgeable and professional. I feel fortunate to be his patient.

Aug 2023

•

Verified SHC Patient

Based on my experience, Joseph Shrager is not only a brilliant surgeon but also an excellent problem solver and a compassionate person who listens to and helps patients facing difficult situations. Thank you Dr. Shrager!

Aug 2023

•

Verified SHC Patient

Dr. Shrager is an excellent doctor who has helped me through my cancer experience. I have greatly appreciated his assistance and support and have only good things to say about him.

Jul 2023

•

Verified SHC Patient

Very helpful! Peace of mind to know he is following and there for whatever may occur.

Jul 2023

•

Verified SHC Patient

Best doctor ever had an experience with extremely knowledgeable

Jul 2023

•

Verified SHC Patient

very informative

Jul 2023

•

Verified SHC Patient

He was clear and helpful.

Jul 2023

•

Verified SHC Patient

Excellent MD.

Jun 2023

•

Verified SHC Patient

Excellent experience. Dr. Schrager listen to all my questions and answered them thoroughly.

May 2023

•

Verified SHC Patient

amazing !

May 2023

•

Verified SHC Patient

Very Nice Doctor

May 2023

•

Verified SHC Patient

He and his staff are excellent and I will recommend him to anyone that needs this service. I am very confident with Standford Health Care services.

May 2023

•

Verified SHC Patient

Dr. Shrager is an awesome doctor. He always made me fell well taken care of.

Apr 2023

•

Verified SHC Patient

This was the first time seeing Dr. Shrager, read his reviews and also he is Standford provider and I am very satisfied with him and Standford medical services.

Mar 2023

•

Verified SHC Patient

Excellent doctor

Mar 2023

•

Verified SHC Patient

He was very professional, easier to understand, and spoke at a nice reasonable pace. He made me feel confident regarding his thoughts and recommendations. He answered my specific questions well. He assured me that doing the surgery would be a worthwhile thing to do.

Feb 2023

•

Verified SHC Patient

Excellent doctor!

Jan 2023

•

Verified SHC Patient

I cannot say enough about the excellent care Dr. Shrager provides, his team is knowlegeable, compassionate, always responsive. Dr. Shrager knows and is experienced, forthright about his field of medicine. I have full confidence in him for my care.

Dec 2022

•

Verified SHC Patient

I appreciate the fact that I was provided with an appointment to be seen very quickly.

Dec 2022

•

Verified SHC Patient

Very professional

Nov 2022

•

Verified SHC Patient

I will not recommend him to see other patients.

Nov 2022

•

Verified SHC Patient

He is warm. courteous,, knowledgeable and enthusiastic, the best one can hope for!

Oct 2022

•

Verified SHC Patient

Answered all my questions. And I felt very confident when the zoom meeting was over.. I have all the confidence that Dr. Shrager will have me back on my feet in no time. He explained the procedure, the time in the hospital, the recovery time and what to expect while recovering

Oct 2022

•

Verified SHC Patient

Very pleasant and answered my questions.....

Oct 2022

•

Verified SHC Patient

Great doctor

Oct 2022

•

Verified SHC Patient

He is very understanding and very thorough in caring patients. He is also knowledgeable and open to share his advice/opinions.

Oct 2022

•

Verified SHC Patient

Warm, competent physician.

Oct 2022

•

Verified SHC Patient

Excellent doctor.

Sep 2022

•

Verified SHC Patient

Very high recommend,

Aug 2022

•

Verified SHC Patient

Very competent during my visit except for the wait time.

Aug 2022

•

Verified SHC Patient

Dr. Shrager and his staff are extremely professional and helpful. It is a pleasure being their patient.

Jul 2022

•

Verified SHC Patient

Dr Shrager is direct and to the point which i really appreciate. He is also kind and empathetic which helps when delivering news. He explains things clearly and gives you the opportunity to ask questions if you have any. Iâ€™m grateful to have him as my doctor and trust my care to him completely.

Jul 2022

•

Verified SHC Patient

His an outstanding Doctor and very well knowledgeable with everything you need to know. Iâ€™m very glad and happy that I had him as my specialist doctor with my condition. Speechless.

Jul 2022

•

Verified SHC Patient

Provider was extremely professional and answered all questions regarding my condition and pending options.

Jul 2022

•

Verified SHC Patient

Overall outstanding knowledge and well informed about my health. Fully prepared for the video appointment.

Jul 2022

•

Verified SHC Patient

Dr. Schrager explained the complete procedure he is to perform.

May 2022

•

Verified SHC Patient

Gave empathy and hope

Apr 2022

•

Verified SHC Patient

Easy to talk to and explains thing well. Answers questions.

Mar 2022

•

Verified SHC Patient

He is a professional doctor and take good care of my health. Thank you Dr Shrager.

Mar 2022

•

Verified SHC Patient

Stanford. Doctors and Staff are the BEST!!!

Feb 2022

•

Verified SHC Patient

I feel extremely fortunate to have Dr. Joseph Shrager managing my lung health. The expertise of his life's study is comforting and frees me from worrying. Sincere thanks to Stanford, Dr Shrager and his team.

Feb 2022

•

Verified SHC Patient

It was a pleasant visit with Dr. Shrager

Feb 2022

•

Verified SHC Patient

Dr shrager is very knowledgeable seems to be expert on this line of surgery. Heâ€™s got a lot of experience

Feb 2022

•

Verified SHC Patient

Easy to talk to, provided suggestions if I thought surgery was not the way to go.

Feb 2022

•

Verified SHC Patient

Listened to my concern and answered thoughtfully.

Jan 2022

•

Verified SHC Patient

Excellent

Jan 2022

•

Verified SHC Patient

I am grateful to Dr, Shrager and his team for the care given to me during my malignant lung cancer treatment. It is likely that today I would not be able to respond to this question without their help.

Jan 2022

•

Verified SHC Patient

Thank you for prompt care.

Jan 2022

•

Verified SHC Patient

He was excellent.

Dec 2021

•

Verified SHC Patient

He's an excellent doctor. Five stars!

Dec 2021

•

Verified SHC Patient

Seems like a nice man. I have confidence in him as a doctor.

Dec 2021

•

Verified SHC Patient

Very personable

Dec 2021

•

Verified SHC Patient

He inspires confidence.

Nov 2021

•

Verified SHC Patient

Dr. Shrager is easy to connect with, was informative, and I feel very comfortable with the decision to go ahead with surgery.

Nov 2021

•

Verified SHC Patient

Thank you!

Oct 2021

•

Verified SHC Patient

Appreciate his time and the way that he described the procedure and what to expect. Also appreciate getting this scheduled quickly.

Oct 2021

•

Verified SHC Patient

He is excellent.

Oct 2021

•

Verified SHC Patient

He was very forthcoming about my case and answered all my questions. I appreciate his directness.

Oct 2021

•

Verified SHC Patient

Dr. Shrager has been wonderful. He has responded quickly and with a sense of urgency to the referral. His treatment has been thorough. Despite the patient/work load he must have, I felt he always knew who I was as an individual. He has been thoughtful, respectful and honest without causing undue fear. I feel lucky that Iâ€™ve been under his care

Oct 2021

•

Verified SHC Patient

I trust his judgement. He is the best one to know what is going on with my wife.

Oct 2021

•

Verified SHC Patient

He is a professional and well experienced physician. He takes good care in all of my follow up appointments. Thank you.

Sep 2021

•

Verified SHC Patient

He was very clear and straight forward, which I appreciate.

Sep 2021

•

Verified SHC Patient

Best Doctor in the business!!! He and his staff are awesome.

Aug 2021

•

Verified SHC Patient

Grateful to have a Dr who is calm, direct, listens, and answers questions. Anyone working with Dr Shrager and is team is lucky.

Aug 2021

•

Verified SHC Patient

I had a great experience with my video call with Dr. Shrager.

Aug 2021

•

Verified SHC Patient

I am truly thankful that I was able to meet Dr. Shrager today. He was forthwith when it came to informing me about my upcoming procedure. I had several questions and he answered all of them so that I could understand every aspect of what is going to be done during the procedure. I am confident that Dr. Shrager is very capable of doing this procedure, I know without a doubt that Dr. Joseph Shrager and Standford will take great care of me!

Jul 2021

•

Verified SHC Patient

Thank God for Dr. Shrager. He made my everyday life so much better & easier. Now, I can live & function normally without the worries of dripping sweat from my hands & armpits & also the embarassment & the anxiety that I had to go through because of this condition. Now I feel so happier & free. Thank you so much Dr. Shrager & God bless you.

Jul 2021

•

Verified SHC Patient

The check-in person was right on time. The NP answered all of my questions with good, clear explanations. Dr Shrager answered all of my questions and told me how things will proceed in the future.

Jul 2021

•

Verified SHC Patient

Lucky to have him.

Jul 2021

•

Verified SHC Patient

He cured my cancer so all is good.

Jul 2021

•

Verified SHC Patient

Very clear and to the point of the matter

Jun 2021

•

Verified SHC Patient

He was informative and let me know what the next steps would be.

Jun 2021

•

Verified SHC Patient

Very thing good, no comment.

Jun 2021

•

Verified SHC Patient

I feel very confident going forward with my surgery since I have met with Dr. Shrager and his capable staff. Dr. Shrager was very patient and answered all my questions. He told me how many of my type of surgery he does a year and I was very impressed.

May 2021

•

Verified SHC Patient

He listened and explained everything in great detail and was very thorough

May 2021

•

Verified SHC Patient

Joseph Shrager MD is a wonderful and caring physician, Iâ€™m lucky to have him as my doctor

May 2021

•

Verified SHC Patient

Excellent doctor. I feel like I am in the best hands possible.

May 2021

•

Verified SHC Patient

Very thorough, good answers to my questions.

Apr 2021

•

Verified SHC Patient

He is very thorough while explaining my test results. He is also friendly and answered all my questions.

Apr 2021

•

Verified SHC Patient

Dr Shrager explained the surgery and was very clear with the process and what to expect after the surgery. He was extremely knowledgeable on my condition. I feel confident he will do a great job

Apr 2021

•

Verified SHC Patient

I have confidence in him.

Apr 2021

•

Verified SHC Patient

Very professional and appeared to be knowledgeable about the details on my condition.

Apr 2021

•

Verified SHC Patient

HE IS THE BEST!!! I've been to many doctors in my lifetime. Dr. Shrager is down to business and gets it done. I feel lucky to have found him.

Apr 2021

•

Verified SHC Patient

The PA and doctor thoroughly explained my problem and scheduled me for a lung biopsy.

Mar 2021

•

Verified SHC Patient

I recommend the provider of care to other people for his kindness & his courtesy.

Mar 2020

•

Verified SHC Patient

Well informed about my care.

Jan 2020

•

Verified SHC Patient

Great experience!

Dec 2019

•

Verified SHC Patient

Dr. Shrager - Efficient, comprehensive, takes action - puts team together - Real professional experience - Knows what he's doing - Took interest in my condition. Superior follow up.

Nov 2019

•

Verified SHC Patient

I have extreme confidence for Dr. Shrager but I sometimes feel he is so RUSHED.

Oct 2019

•

Verified SHC Patient

I had a very successful surgery and I'm very thankful to Dr. Shrager, Joseph Ben.

Oct 2019

•

Verified SHC Patient

He does the best he can within the limits of training he does have.

Oct 2019

•

Verified SHC Patient

Excellent experience.

Sep 2019

•

Verified SHC Patient

Dr. Shrager gave me honest answers, including expectations. That information helped me make decisions for myself. He's an excellent provider.

Sep 2019

•

Verified SHC Patient

Very friendly, very professional, a remarkable DOCTOR and also caring and concern about the patient.

Aug 2019

•

Verified SHC Patient

Dr. Shrager was great!

Jul 2019

•

Verified SHC Patient

I am very thankful for Dr. Shrager, Joseph Ben, MD. God bless him and his home!

May 2019

•

Verified SHC Patient

We are blessed to have Dr. Shrager as our caregiver. We are very relieved & trust his care.

May 2019

•

Verified SHC Patient

Dr. Shrager and his entire team took time to talk through all my questions, prognosis etc.

Apr 2019

•

Verified SHC Patient

Prof. Shrager is an excellent doctor treating his patients with a great care.

Mar 2019

•

Verified SHC Patient

Excellent!

Feb 2019

•

Verified SHC Patient

Providers made visit a good experience & answered the questions I had.

Jan 2019

•

Verified SHC Patient

I hope on one I know gets this cancer - but if they do I would recommend Dr. Shrager.

Nov 2018

•

Verified SHC Patient

I'm satisfied.

Sep 2018

•

Verified SHC Patient

We are so lucky that Dr. Shrager is in my dad's insurance network!

Aug 2018

•

Verified SHC Patient

+ = superb!!

Jun 2018

•

Verified SHC Patient

I have been given a second chance at life thank to Dr. Shrager and God!! Always a good experience.

Jun 2018

•

Verified SHC Patient

Always courteous and professional.

Apr 2018

•

Verified SHC Patient

It couldn't have been better!

Mar 2018

•

Verified SHC Patient

Helpful & encouraging -

Feb 2018

•

Verified SHC Patient

Both the doctor & the NP were excellent.

Jan 2018

•

Verified SHC Patient

Dr. Shrager made me feel safe in his care.

Nov 2017

•

Verified SHC Patient

Overall satisfactory.

Nov 2017

•

Verified SHC Patient

Was completely satisfied with my choice of selecting Stanford Univ. found I had received an outstanding health care experience.

Jul 2017

•

Verified SHC Patient

The best doctor I have ever met. Very fortunate to have Dr. Shrager for the surgery. I highly appreciate his effort an less staff! I have had 2 surgeons before. He is the best for my quick recovery.

Jun 2017

•

Verified SHC Patient

I have nothing but praise for Dr Shrager & his staff. I am fortunate that I have such highly qualified caregivers.

Jun 2017

•

Verified SHC Patient

Outstanding experience!!!

Apr 2017

•

Verified SHC Patient

Very good.

Mar 2017

•

Verified SHC Patient

He & she were wonderful.

Mar 2017

•

Verified SHC Patient

Very professional & efficient.

Feb 2017

•

Verified SHC Patient

Dr. Shrager is amazing and extremely kind & caring.

Dec 2016

•

Verified SHC Patient

Excellent person very explicit.

Dec 2016

•

Verified SHC Patient

The care provider and nurse are concern with the patient's health condition.

Nov 2016

•

Verified SHC Patient

I was actually surprised by how accessible Dr. Shrager was especially for scheduling surgery so quickly, I actually came to Dr. Shrager for a second opinion, and after meeting with him, decided to have him do my surgery! He is impressive!

Nov 2016

•

Verified SHC Patient

I would refer my friends to this doctor or hospital.

Aug 2016

•

Verified SHC Patient

Went well.

Aug 2016

•

Verified SHC Patient

World class surgeon, but also absolutely outstanding physician w/patient.

Aug 2016

•

Verified SHC Patient

Dr. Shrager is obviously an excellent surgeon. However, his "bedside manner" is a little cold and stiff and abrupt.

Aug 2016

•

Verified SHC Patient

Very good & helpful experience.

Jul 2016

•

Verified SHC Patient

Good experience.

Apr 2016

•

Verified SHC Patient

Very good.

Apr 2016

•

Verified SHC Patient

Excellent doctors. Straight forward, no B.S. Quite possibly saved my life!

Apr 2016

•

Verified SHC Patient

Dr. Shrager is my hero.

Apr 2016

•

Verified SHC Patient

Love Dr. Shrager! He was very knowledgeable and if he had any concerns/questions he call the oncologist so our questions would be answered!

Mar 2016

•

Verified SHC Patient

I expected the doctor to spend a little time with me - even to bring up/open my CT and other scans; I expected a REVIEW of my cancer and the most vacant scan and I received NONE of this. I surprised and disappointed me entirely - After all, this is STANFORD.

Mar 2016

•

Verified SHC Patient

My experience was so amazing! I felt so lucky to be able to get such amazing care & prompt surgery.

Jan 2016

•

Verified SHC Patient

Coming from a rural setting, the quality of care and efficiencies are truly stunning -

Jan 2016

•

Verified SHC Patient

Dr. Shrager was smart, direct, & competent.

Jan 2016

•

Verified SHC Patient

All Good!

Dec 2015

•

Verified SHC Patient

The best!

Dec 2015

•

Verified SHC Patient

Love Dr. Shrager and Angela. Just wish I had come to them sooner. I especially appreciated Dr. Shrager's compassion when he had to tell me my tumor was Stage II instead of Stage I after all. Thanks.

Nov 2015

•

Verified SHC Patient

Provided every thing I needed to know & understand.

Nov 2015

•

Verified SHC Patient

A very great dr.

Oct 2015

•

Verified SHC Patient

Everyone is very conscientious! Actual time seeing doctor felt rushed.

Sep 2015

•

Verified SHC Patient

Excellent.

Jul 2015

•

Verified SHC Patient

I was weak from surgery & needed more specific advise about how to heal more quickly & did not get that. However. Dr. Shrager did a great job with surgery & referred me to Dr. Heather Walker.

Jun 2015

•

Verified SHC Patient

Wanted more info about 2 spots on my lung -> New or old & seen before now?

May 2015

•

Verified SHC Patient

Dr. Shrager, is an excellent thoracic surgeon. May God keep blessing him in his noble work!

May 2015

•

Verified SHC Patient

I would definitely recommend it!

May 2015

•

Verified SHC Patient

Excellent.

Mar 2015

•

Verified SHC Patient

Dr. Shrager an excellent surgeon - brisk and to the point.

Feb 2015

•

Verified SHC Patient

The entire experience was VERY positive.

Jan 2015

•

Verified SHC Patient

Excellent.

Dec 2014

•

Verified SHC Patient

Dr. Shrager is an excellent doctor!

Dec 2014

•

Verified SHC Patient

The best provider. He is #1.

Oct 2014

•

Verified SHC Patient

I could have been more aware of what I needed to know. My first surgery hospital stay in 50+ years I was not knowledgeable of hospital protocol.

Sep 2014

•

Verified SHC Patient

Dr. Shrager & staff offer superior care and I feel very fortunate to have had him as my surgeon. Everything about his clinic is top-notch and he really cares about his patients but also provides the best care possible.

Sep 2014

•

Verified SHC Patient

Limited experience with ACC cancer. Some of his comments went against what I know of the disease.

Jul 2014

•

Verified SHC Patient

Dr. Shrager is an excellent doctor and I feel very fortunate to be his patient.

May 2014

•

Verified SHC Patient

Staff was outstanding and very helpful as well as available.

May 2014

•

Verified SHC Patient

Excellent - professional - gave me confidence that I was in the best hands.

May 2014

•

Verified SHC Patient

The intern was so informative and Dr. Shrager told me more than I have been able to understand and answered questions - than I have in the last several months of my dr. in home town.

Mar 2014

•

Verified SHC Patient

Excellent doctor in MANY ways!! I did feel slightly rushed in my last visit though.

Dec 2013

•

Verified SHC Patient

View More Patient Reviews

Referring Physicians

PHYSICIAN HELPLINE

Phone: 1-866-742-4811
Fax: 650-320-9443
Monday–Friday, 8 a.m.–5 p.m.

Stanford Health Care provides comprehensive services to refer and track patients, as well as the latest information and news for physicians and office staff. For help with all referral needs and questions, visit Referral Information.

You may also submit a web referral or complete a referral form and fax it to 650-320-9443 or email the Referral Center at ReferralCenter@stanfordhealthcare.org.

Send referrals online
Place radiology and lab orders
View referral status
Access medical records

Learn More About MedLink

LOG INTO MEDLINK

New to MyHealth?

ALREADY HAVE AN ACCESS CODE?

DON'T HAVE AN ACCESS CODE?

NEED MORE DETAILS?

MyHealth for Mobile

Joseph Shrager

Thoracic surgeon, Surgical oncologist

Get In Touch

Biography

Professional Summary

Education & Certifications

Honors & Awards

Memberships

Administrative Appointments

Publications

Clinical Trials

Specializing In

Practice Locations

Thoracic Surgery Clinic in Palo Alto Palo Alto, CA

Thoracic Surgery Clinic in Palo Alto

Thoracic Cancer Program in Palo Alto Palo Alto, CA

Thoracic Cancer Program in Palo Alto

Esophagus Center Redwood City, CA

Esophagus Center

Chest Wall Surgery Program Palo Alto, CA

Chest Wall Surgery Program

Important Information about Our Organizations and Physician Affiliation

Patient Ratings

How Our Ratings Work

Patient Reviews

(202 reviews)

Referring Physicians

PHYSICIAN HELPLINE

New to MyHealth?

ALREADY HAVE AN ACCESS CODE?

DON'T HAVE AN ACCESS CODE?

NEED MORE DETAILS?

MyHealth for Mobile

WELCOME BACK

Joseph Shrager

Thoracic surgeon, Surgical oncologist

Get In Touch

Biography

Professional Summary

Education & Certifications

Honors & Awards

Memberships

Administrative Appointments

Publications

Clinical Trials

Specializing In

Practice Locations

Thoracic Surgery Clinic in Palo Alto Palo Alto, CA

Thoracic Surgery Clinic in Palo Alto

Thoracic Cancer Program in Palo Alto Palo Alto, CA

Thoracic Cancer Program in Palo Alto

Esophagus Center Redwood City, CA

Esophagus Center

Chest Wall Surgery Program Palo Alto, CA

Chest Wall Surgery Program

Important Information about Our Organizations and Physician Affiliation

Patient Ratings

How Our Ratings Work

Patient Reviews

(202 reviews)

Referring Physicians

PHYSICIAN HELPLINE